<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">69982</article-id><article-id pub-id-type="doi">10.7554/eLife.69982</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-239176"><name><surname>Lopes</surname><given-names>Noella</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6296-8426</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-239175"><name><surname>Boucherit</surname><given-names>Nicolas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-264920"><name><surname>Santamaria</surname><given-names>Jérémy C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7613-3668</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-264921"><name><surname>Provin</surname><given-names>Nathan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-239177"><name><surname>Charaix</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-239178"><name><surname>Ferrier</surname><given-names>Pierre</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-162131"><name><surname>Giraud</surname><given-names>Matthieu</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1208-9677</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-179007"><name><surname>Irla</surname><given-names>Magali</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8803-9708</contrib-id><email>Magali.Irla@inserm.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/035xkbk20</institution-id><institution>Aix-Marseille University, CNRS, INSERM, Centre d'Immunologie de Marseille-Luminy</institution></institution-wrap><addr-line><named-content content-type="city">Marseille</named-content></addr-line><country>France</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03gnr7b55</institution-id><institution>Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064</institution></institution-wrap><addr-line><named-content content-type="city">Nantes</named-content></addr-line><country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Russell</surname><given-names>Sarah</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a8bt934</institution-id><institution>Peter MacCallum Cancer Centre</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Taniguchi</surname><given-names>Tadatsugu</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/057zh3y96</institution-id><institution>Institute of Industrial Science, The University of Tokyo</institution></institution-wrap><country>Japan</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>21</day><month>02</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e69982</elocation-id><history><date date-type="received" iso-8601-date="2021-05-03"><day>03</day><month>05</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2022-01-14"><day>14</day><month>01</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2020-11-29"><day>29</day><month>11</month><year>2020</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2020.11.29.399923"/></event></pub-history><permissions><copyright-statement>© 2022, Lopes et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Lopes et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-69982-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-69982-figures-v2.pdf"/><abstract><p>Interactions of developing T cells with Aire<sup>+</sup> medullary thymic epithelial cells expressing high levels of MHCII molecules (mTEC<sup>hi</sup>) are critical for the induction of central tolerance in the thymus. In turn, thymocytes regulate the cellularity of Aire<sup>+</sup> mTEC<sup>hi</sup>. However, it remains unknown whether thymocytes control the precursors of Aire<sup>+</sup> mTEC<sup>hi</sup> that are contained in mTEC<sup>lo</sup> cells or other mTEC<sup>lo</sup> subsets that have recently been delineated by single-cell transcriptomic analyses. Here, using three distinct transgenic mouse models, in which antigen presentation between mTECs and CD4<sup>+</sup> thymocytes is perturbed, we show by high-throughput RNA-seq that self-reactive CD4<sup>+</sup> thymocytes induce key transcriptional regulators in mTEC<sup>lo</sup> and control the composition of mTEC<sup>lo</sup> subsets, including Aire<sup>+</sup> mTEC<sup>hi</sup> precursors, post-Aire and tuft-like mTECs. Furthermore, these interactions upregulate the expression of tissue-restricted self-antigens, cytokines, chemokines, and adhesion molecules important for T-cell development. This gene activation program induced in mTEC<sup>lo</sup> is combined with a global increase of the active H3K4me3 histone mark. Finally, we demonstrate that these self-reactive interactions between CD4<sup>+</sup> thymocytes and mTECs critically prevent multiorgan autoimmunity. Our genome-wide study thus reveals that self-reactive CD4<sup>+</sup> thymocytes control multiple unsuspected facets from immature stages of mTECs, which determines their heterogeneity.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>thymus</kwd><kwd>tolerance</kwd><kwd>medullary thymic epithelial cells</kwd><kwd>cellular crosstalk</kwd><kwd>T cells</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010665</institution-id><institution>H2020 Marie Skłodowska-Curie Actions</institution></institution-wrap></funding-source><award-id>CIG_SIGnEPI4Tol_618541</award-id><principal-award-recipient><name><surname>Irla</surname><given-names>Magali</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>2011-CHEX-001-R12004KK</award-id><principal-award-recipient><name><surname>Giraud</surname><given-names>Matthieu</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-19-CE18-0021-01 RANKLthym</award-id><principal-award-recipient><name><surname>Irla</surname><given-names>Magali</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Self-reactive CD4<sup>+</sup> thymocytes have a broad impact on the composition of medullary thymic epithelial cell (mTEC) subsets by acting upstream of Aire<sup>+</sup> mTECs, which conditions the induction of T-cell tolerance.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The thymic medulla ensures the generation of a self-tolerant T-cell repertoire (<xref ref-type="bibr" rid="bib35">Klein et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Lopes et al., 2015</xref>). By their unique ability to express tissue-restricted self-antigens (TRAs) (<xref ref-type="bibr" rid="bib16">Derbinski et al., 2001</xref>; <xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>), medullary thymic epithelial cells (mTECs) promote the development of Foxp3<sup>+</sup> regulatory T cells and the deletion by apoptosis of self-reactive thymocytes capable of inducing autoimmunity (<xref ref-type="bibr" rid="bib36">Klein et al., 2019</xref>). The expression of TRAs that mirrors body’s self-antigens is controlled by Aire (<italic>Autoimmune regulator</italic>) and Fezf2 (<italic>Fez family zinc finger 2</italic>) transcription factors (<xref ref-type="bibr" rid="bib4">Anderson et al., 2002</xref>; <xref ref-type="bibr" rid="bib64">Takaba et al., 2015</xref>). Aire-dependent TRAs are generally characterized by a repressive chromatin state enriched in the trimethylation of lysine-27 of histone H3 (H3K27me3) histone mark (<xref ref-type="bibr" rid="bib25">Handel et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Org et al., 2009</xref>; <xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>). In accordance with their essential role in regulating the expression of TRAs, <italic>Aire</italic><sup>-/-</sup> and <italic>Fezf2</italic><sup>-/-</sup> mice show defective clonal deletion of autoreactive thymocytes and develop signs of autoimmunity in several peripheral tissues (<xref ref-type="bibr" rid="bib4">Anderson et al., 2002</xref>; <xref ref-type="bibr" rid="bib64">Takaba et al., 2015</xref>).</p><p>Based on the level of the co-expressed MHC class II and CD80 molecules, mTECs were initially subdivided into mTEC<sup>lo</sup> (MHCII<sup>lo</sup>CD80<sup>lo</sup>) and mTEC<sup>hi</sup> (MHCII<sup>hi</sup>CD80<sup>hi</sup>) (<xref ref-type="bibr" rid="bib22">Gray et al., 2006</xref>). The relationship between these two subsets has been established with reaggregate thymus organ cultures in which mTEC<sup>lo</sup> give rise to mature Aire<sup>+</sup> mTEC<sup>hi</sup> (<xref ref-type="bibr" rid="bib19">Gäbler et al., 2007</xref>; <xref ref-type="bibr" rid="bib23">Gray et al., 2007</xref>). Although mTEC<sup>hi</sup> express a highly diverse array of TRAs under Aire’s action that releases stalled RNA polymerase and modulates chromatin accessibility, mTEC<sup>lo</sup> already express a substantial amount of TRAs (<xref ref-type="bibr" rid="bib17">Derbinski et al., 2005</xref>; <xref ref-type="bibr" rid="bib20">Giraud et al., 2012</xref>; <xref ref-type="bibr" rid="bib37">Koh et al., 2018</xref>; <xref ref-type="bibr" rid="bib40">Kyewski and Klein, 2006</xref>; <xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>). Recent single-cell transcriptomic analyses indicate that the heterogeneity of mTECs, especially in the mTEC<sup>lo</sup> compartment, is more complex than previously thought (<xref ref-type="bibr" rid="bib32">Irla, 2020</xref>; <xref ref-type="bibr" rid="bib33">Kadouri et al., 2020</xref>). mTEC<sup>lo</sup> with low or no expression of CD80 have been shown to be divided into three main subsets: CCL21<sup>+</sup> mTECs, implicated in the attraction of positively selected thymocytes in the medulla (<xref ref-type="bibr" rid="bib43">Lkhagvasuren et al., 2013</xref>), involucrin<sup>+</sup>TPA<sup>hi</sup> post-Aire mTECs corresponding to the ultimate mTEC differentiation stage (<xref ref-type="bibr" rid="bib49">Metzger et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Michel et al., 2017</xref>; <xref ref-type="bibr" rid="bib52">Nishikawa et al., 2010</xref>), and the newly reported tuft-like mTECs that show properties of gut chemosensory epithelial tuft cells expressing the doublecortin-like kinase 1 (DCLK1) marker (<xref ref-type="bibr" rid="bib10">Bornstein et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Miller et al., 2018</xref>). Based on single-cell transcriptomic analyses, mTECs were then classified into four major groups encompassing mTEC I:CCL21<sup>+</sup> mTECs, mTEC II:Aire<sup>+</sup> mTECs, mTEC III:post-Aire mTECs, and mTEC IV:tuft-like mTECs (<xref ref-type="bibr" rid="bib10">Bornstein et al., 2018</xref>). Furthermore, mTEC<sup>lo</sup> with intermediate levels of CD80 and MHCII lie into mTEC single-cell clusters that are defined as proliferating and maturational, expressing Fezf2 and preceding the Aire<sup>+</sup> mTEC<sup>hi</sup> stage (<xref ref-type="bibr" rid="bib7">Baran-Gale et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Dhalla et al., 2020</xref>). These transit-amplifying cells were recently referred as to as TAC-TECs (<xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>).</p><p>In the postnatal thymus, while mTECs control the selection of thymocytes, conversely CD4<sup>+</sup> thymocytes control the cellularity of Aire<sup>+</sup> mTEC<sup>hi</sup> by activating RANK and CD40-induced NF-κb signaling pathways (<xref ref-type="bibr" rid="bib2">Akiyama et al., 2008</xref>; <xref ref-type="bibr" rid="bib27">Hikosaka et al., 2008</xref>; <xref ref-type="bibr" rid="bib32">Irla, 2020</xref>; <xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>). These bidirectional interactions between mTECs and thymocytes are commonly referred to as thymic crosstalk (<xref ref-type="bibr" rid="bib45">Lopes et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">van Ewijk et al., 1994</xref>). However, it remains unknown whether CD4<sup>+</sup> thymocytes act exclusively on mature Aire<sup>+</sup> mTEC<sup>hi</sup> or upstream on their TAC-TEC precursors contained in mTEC<sup>lo</sup> and whether the development of the newly identified Fezf2<sup>+</sup>, post-Aire, and tuft-like subsets is regulated or not by CD4<sup>+</sup> thymocytes.</p><p>In this study, using high-throughput RNA-sequencing (RNA-seq), we show that self-reactive CD4<sup>+</sup> thymocytes induce in mTEC<sup>lo</sup> pivotal transcriptional regulators for their differentiation and function. Accordingly, self-reactive CD4<sup>+</sup> thymocytes control the composition of the mTEC<sup>lo</sup> compartment, that is the precursors of Aire<sup>+</sup> mTEC<sup>hi</sup>, post-Aire cells, and tuft-like mTECs. Our data also reveal that self-reactive CD4<sup>+</sup> thymocytes upregulate in mTEC<sup>lo</sup> the expression of TRAs, chemokines, cytokines, and adhesion molecules involved in T-cell development. This gene activation program correlates with increased levels of the active trimethylation of lysine-4 of histone 3 (H3K4me3) mark, including the loci of Fezf2-dependent and Aire/Fezf2-independent TRAs, indicative of an epigenetic regulation for their expression. Finally, we demonstrate that disrupted MHCII/TCR interactions between mTECs and CD4<sup>+</sup> thymocytes lead to the generation of mature T cells containing self-specificities capable of inducing multiorgan autoimmunity. Altogether, our genome-wide study reveals that self-reactive CD4<sup>+</sup> thymocytes control the developmental transcriptional programs of mTEC<sup>lo</sup>, which conditions their differentiation and function as inducers of T-cell tolerance.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>CD4<sup>+</sup> thymocytes induce key transcriptional programs in mTEC<sup>lo</sup> cells</title><p>Several NF-κb members are involved in Aire<sup>+</sup> mTEC<sup>hi</sup> development (<xref ref-type="bibr" rid="bib11">Burkly et al., 1995</xref>; <xref ref-type="bibr" rid="bib44">Lomada et al., 2007</xref>; <xref ref-type="bibr" rid="bib56">Riemann et al., 2017</xref>; <xref ref-type="bibr" rid="bib61">Shen et al., 2019</xref>; <xref ref-type="bibr" rid="bib76">Zhang et al., 2006</xref>). However, it remains unclear whether the NF-κb or other signaling pathways are activated by CD4<sup>+</sup> thymocytes specifically in mTEC<sup>lo</sup> cells. To investigate the effects of CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup>, we used mice deficient in CD4<sup>+</sup> thymocytes (ΔCD4 mice) because they lack the promoter IV of the class II transactivator (<italic>Ciita</italic>) gene that controls MHCII expression in cortical TECs (cTECs) (<xref ref-type="bibr" rid="bib70">Waldburger et al., 2003</xref>). We first analyzed by flow cytometry the total and phosphorylated forms of IKKα, p65, and RelB NF-κb members and p38 and Erk1/2 MAPK proteins in mTEC<sup>lo</sup> from ΔCD4 mice according to the gating strategy shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. Interestingly, the phosphorylation level of IKKα and p38 MAPK was substantially reduced in ΔCD4 mice (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>), indicating that CD4<sup>+</sup> thymocytes may have an impact in mTEC<sup>lo</sup> by activating the IKKα intermediate of the nonclassical NF-κB pathway and the p38 MAPK pathway.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>The transcriptional profile and IKKα and p38 MAPK signaling pathways are impaired in mTEC<sup>lo</sup> of ΔCD4 mice.</title><p>(<bold>A, B</bold>) Total IKKα, p38 MAPK, phospho-IKKα(Ser180)/IKKβ(Ser181), and p38 MAPK (Thr180/Tyr182) (<bold>A</bold>) and the ratio of phospho/total proteins (<bold>B</bold>) analyzed by flow cytometry in mTEC<sup>lo</sup> from WT and ΔCD4 mice. Data are representative of two independent experiments (n = 3–4 mice per group and experiment). (<bold>C</bold>) Scatter plot of gene expression levels (fragments per kilobase of transcript per million mapped reads [FPKM]) of mTEC<sup>lo</sup> from WT versus ΔCD4 mice. Genes with fold difference ≥2 and p-adj&lt;0.05 were considered as upregulated or downregulated genes (red and blue dots, respectively). RNA-seq was performed on two independent biological replicates with mTEC<sup>lo</sup> derived from 3 to 5 mice. (<bold>D</bold>) Numbers of tissue-restricted self-antigens (TRAs) and non-TRAs in genes up- and downregulated (left panel) and the proportion of upregulated TRAs compared to those in the all genome (right panel). ND, not determined. (<bold>E</bold>) Numbers of induced Aire-dependent, Fezf2-dependent, Aire/Fezf2-dependent, and Aire/Fezf2-independent TRAs. (<bold>F</bold>) The expression of Aire-dependent (<italic>Meig1, Nov</italic>), Fezf2-dependent (<italic>Fcer2a, Kcnj5</italic>), Aire/Fezf2-dependent (<italic>Krt1, Reig1</italic>), and Aire/Fezf2-independent (<italic>Crp, Rsph1</italic>) TRAs measured by qPCR in WT (n = 3–4) and ΔCD4 (n = 3–4) mTEC<sup>lo</sup>. (<bold>G</bold>) Expression fold change in HDAC3-induced transcriptional regulators and other transcription factors significantly upregulated in WT versus ΔCD4 mTEC<sup>lo</sup>. The color code represents gene expression level. (<bold>H</bold>) Heatmaps of genes encoding for cell adhesion molecules and cytokines that were significantly downregulated in mTEC<sup>lo</sup> from ΔCD4 mice. (<bold>I</bold>) Hierarchical clustering and heatmap of mean expression of these cell adhesion molecules and cytokines in mTEC subsets identified by scRNA-seq. Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01 using two-tailed Mann–Whitney test for (<bold>A</bold>), (<bold>B</bold>) and (<bold>F</bold>) and chi-squared test for (<bold>D</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Gating strategy used to purify mTEC<sup>lo</sup> cells.</title><p>(<bold>A</bold>) Total thymic epithelial cells (TECs) were defined as EpCAM<sup>+</sup> in CD45-negative enriched thymic cells by autoMACS and were further divided into medullary TECs (mTECs) (UEA-1<sup>+</sup>Ly51<sup>lo</sup>) and cortical TECs (cTECs) (UEA-1<sup>−</sup>Ly51<sup>hi</sup>). mTEC<sup>lo</sup> were identified and sorted based on low/intermediate levels of the CD80 co-stimulatory molecule. The purity of sorted mTEC<sup>lo</sup> was &gt;98%. (<bold>B</bold>) Gates used to sort mTEC<sup>lo</sup> from WT, ΔCD4, mTEC<sup>ΔMHCII</sup>, RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup>, and OTII-<italic>Rag2</italic><sup>-/-</sup> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Normal total and phosphorylated p65, RelB, and Erk1/2 proteins in mTEC<sup>lo</sup> from ΔCD4 mice.</title><p>Total p65, RelB, and Erk1/2 (<bold>A</bold>) and phospho-p65 (Ser536), phospho-RelB (Ser552), and phospho-Erk1/2 (Thr202/Tyr204) (<bold>B</bold>) proteins were analyzed by flow cytometry in mTEC<sup>lo</sup> of WT and ΔCD4 mice. Histograms show the MFI. II Abs: secondary antibodies. Data are representative of two independent experiments (n = 2–3 mice per group and experiment). Error bars show mean ± SEM, *p&lt;0.05 using the Mann–Whitney test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Impaired TRA expression in mTEC<sup>lo</sup> from MHCII<sup>-/-</sup> mice.</title><p>(<bold>A</bold>) The expression of Aire-dependent (<italic>Meig1, Nov</italic>), Fezf2-dependent (<italic>Fcer2a, Kcnj5</italic>), Aire/Fezf2-dependent (<italic>Krt1, Reig1</italic>), and Aire/Fezf2-independent (<italic>Crp, Rsph1</italic>) tissue-restricted self-antigens (TRAs) was measured by qPCR in purified mTEC<sup>lo</sup> from WT (n = 3), ΔCD4 (n = 3), and MHCII<sup>-/-</sup> (n = 3) mice. (<bold>B</bold>) <italic>Itgb6, Cdh2, Il21,</italic> and <italic>Il5</italic> mRNAs were measured by qPCR in WT (n = 4) and ΔCD4 (n = 4) mTEC<sup>lo</sup>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Identification of thymic epithelial cell (TEC) subsets by single-cell RNA-seq.</title><p>(<bold>A</bold>) UMAP visualization of single-cell RNA-seq data on TECs reanalyzed from <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>. Six clusters were identified corresponding to cortical TECs (cTECs), CCL21<sup>+</sup> medullary TECs (mTECs) (mTEC I), TAC-TECs (transit-amplifying cells), Aire<sup>+</sup> (mTEC II), post-Aire (mTEC III), and Tuft-like (mTEC IV) mTECs. (<bold>B</bold>) Expression of selected marker genes overlaid on UMAP visualization. Scale bars represent the log2 expression of the indicated genes.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig1-figsupp4-v2.tif"/></fig></fig-group><p>To gain insights into the effects of CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup>, we analyzed by high-throughput RNA-seq the gene expression profiles of mTEC<sup>lo</sup> purified from WT and ΔCD4 mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). We found that CD4<sup>+</sup> thymocytes upregulated 989 genes (fold change [FC] &gt;2) reaching significance for 248 of them (Cuffdiff p&lt;0.05) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). 957 genes were also downregulated (FC &lt; 0.5) with 178 genes reaching significance (Cuffdiff p&lt;0.05). We analyzed whether the genes significantly up- or downregulated by CD4<sup>+</sup> thymocytes corresponded to TRAs, as defined by an expression restricted to 1–5 of peripheral tissues (<xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>). Interestingly, the genes upregulated by CD4<sup>+</sup> thymocytes exhibited approximately fourfold more of TRAs over non-TRAs (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, left panel). The comparison of the proportion of TRAs among the upregulated genes with those of the genome revealed a strong statistical TRA overrepresentation (p=5.2 × 10<sup>–10</sup>) (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, right panel). Most of the TRAs upregulated by CD4<sup>+</sup> thymocytes were sensitive to the action of Aire (Aire-dependent TRAs) or controlled by Aire and Fezf2-independent mechanisms (Aire/Fezf2-independent TRAs) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The upregulation of some of these TRAs by CD4<sup>+</sup> thymocytes was confirmed by qPCR in mTEC<sup>lo</sup> purified from ΔCD4 mice (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). The same results were observed with mTEC<sup>lo</sup> purified from MHCII<sup>-/-</sup> mice, also lacking CD4<sup>+</sup> thymocytes, excluding any potential indirect effect of CIITA in the phenotype observed in ΔCD4 mice (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>).</p><p>Remarkably, among the non-TRAs upregulated by CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup>, 37 corresponded to 50 mTEC-specific transcription factors that are induced by the histone deacetylase 3 (HDAC3) (<xref ref-type="bibr" rid="bib21">Goldfarb et al., 2016</xref>; <xref ref-type="fig" rid="fig1">Figure 1G</xref>). Some of them, such as the interferon regulatory factor 4 (<italic>Irf4</italic>), <italic>Irf7,</italic> and the Ets transcription factor member, <italic>Spib,</italic> are known to regulate mTEC differentiation and function (<xref ref-type="bibr" rid="bib3">Akiyama et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Haljasorg et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Otero et al., 2013</xref>). We also identified other transcription factors such as <italic>Nfkb2</italic>, <italic>Trp53,</italic> and <italic>Relb</italic> implicated in mTEC differentiation (<xref ref-type="bibr" rid="bib56">Riemann et al., 2017</xref>; <xref ref-type="bibr" rid="bib58">Rodrigues et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Zhang et al., 2006</xref>). Finally, we found that CD4<sup>+</sup> thymocytes upregulate in mTEC<sup>lo</sup> the expression of some cytokines and cell adhesion molecules such as integrins and cadherins (<xref ref-type="fig" rid="fig1">Figure 1H</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>). Given that mTEC<sup>lo</sup> are heterogeneous (<xref ref-type="bibr" rid="bib32">Irla, 2020</xref>; <xref ref-type="bibr" rid="bib33">Kadouri et al., 2020</xref>), we then analyzed whether the cytokines and adhesion molecules, which are upregulated by CD4<sup>+</sup> thymocytes, are specific to a particular subset of mTEC<sup>lo</sup>. To this end, we reanalyzed single-cell RNA-seq data performed on total CD45<sup>-</sup>EpCAM<sup>+</sup> TECs (<xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>). Single cells were projected into a UMAP reduced-dimensional space and, using the 15 first principal components, six clusters were obtained, as in <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref> (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4A</xref>). Well-established markers were used to distinguish the different TEC subsets such as <italic>Psmb11</italic> and <italic>Prss16</italic> for cTECs, <italic>Ccl21a</italic> and <italic>Krt5</italic> for CCL21<sup>+</sup> mTECs (also called mTEC I), <italic>Stmn1, Ska1, Fezf2</italic> and <italic>Aire</italic> for TAC-TECs, <italic>Aire</italic> and <italic>Fezf2</italic> for Aire<sup>+</sup> mTECs (also called mTEC II), <italic>Pigr</italic> and <italic>Cldn3</italic> for post-Aire mTECs (also called mTEC III), and <italic>Avil</italic> and <italic>Pou2f3</italic> for tuft-like mTECs (also called mTEC IV) (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4B</xref>). In contrast to CCL21<sup>+</sup> mTECs, some genes upregulated by CD4<sup>+</sup> thymocytes were expressed by tuft-like mTECs (<xref ref-type="fig" rid="fig1">Figure 1I</xref>). Interestingly, many genes encoding for cytokines and cell adhesion molecules were associated with Aire<sup>+</sup> mTECs and post-Aire cells with some of them already expressed in TAC-TECs, suggesting that CD4<sup>+</sup> thymocytes may act upstream of Aire<sup>+</sup> mTEC<sup>hi</sup>. These results thus provide the first evidence that CD4<sup>+</sup> thymocytes are able to induce in mTEC<sup>lo</sup> essential transcriptional regulators for mTEC differentiation and function as well as TRAs, adhesion molecules, and cytokines.</p></sec><sec id="s2-2"><title>CD4<sup>+</sup> thymocytes regulate maturational programs in mTEC<sup>lo</sup> through MHCII/TCR interactions</title><p>We next investigated by which mechanism CD4<sup>+</sup> thymocytes regulate the transcriptional programs of mTEC<sup>lo</sup>. Given that MHCII/TCR interactions with mTECs are critical for CD4<sup>+</sup> T-cell selection (<xref ref-type="bibr" rid="bib36">Klein et al., 2019</xref>), we hypothesized that these interactions could play an important role in initiating transcriptional programs that govern the functional and developmental properties of mTEC<sup>lo</sup>. To this end, we used a unique transgenic mouse model in which MHCII expression is selectively abrogated in mTECs (mTEC<sup>ΔMHCII</sup> mice) (<xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>). In contrast to their WT counterparts, we found that OVA<sub>323-339</sub>-loaded mTECs from mTEC<sup>ΔMHCII</sup> mice were ineffective at activating OTII-specific CD4<sup>+</sup> T cells, demonstrating that the capacity of antigen presentation of mTECs to CD4<sup>+</sup> T cells is impaired in these mice (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The transcriptional and functional properties of mTEC<sup>lo</sup> are impaired in mTEC<sup>ΔMHCII</sup> mice.</title><p>(<bold>A</bold>) Percentages of CD69<sup>+</sup> OTII CD4<sup>+</sup> T cells cultured or not with variable numbers of OVA<sub>323-339</sub>-loaded WT or mTEC<sup>ΔMHCII</sup> mTECs derived from two independent experiments (n = 2–3 mice per group and experiment). (<bold>B</bold>) Scatter plot of gene expression levels (fragments per kilobase of transcript per million mapped reads [FPKM]) of mTEC<sup>lo</sup> from WT versus mTEC<sup>ΔMHCII</sup> mice. Genes with fold difference ≥2 and p-adj&lt;0.05 were considered as upregulated or downregulated genes (red and blue dots, respectively). RNA-seq was performed on two independent biological replicates with mTEC<sup>lo</sup> derived from 3 to 5 mice. (<bold>C</bold>) Numbers of tissue-restricted self-antigens (TRAs) and non-TRAs in genes up- and downregulated in mTEC<sup>lo</sup> from WT versus mTEC<sup>ΔMHCII</sup> mice. ND, not determined. (<bold>D</bold>) Numbers of induced TRAs regulated or not by Aire and/or Fezf2. (<bold>E</bold>) Aire-dependent (<italic>Crabp1</italic>), Fezf2-dependent (<italic>Coch, Sult1c2</italic>), Aire/Fezf2-dependent (<italic>Fabp9</italic>), and Aire/Fezf2-independent (<italic>Spon2, Upk3b</italic>) TRAs were measured by qPCR in mTEC<sup>lo</sup> from WT (n = 4) and mTEC<sup>ΔMHCII</sup> (n = 4) mice. (<bold>F</bold>) Scatter plot of gene expression variation in mTEC<sup>lo</sup> from WT versus mTEC<sup>ΔMHCII</sup> mice and in mTEC<sup>hi</sup> from WT versus <italic>Aire</italic><sup>-/-</sup> mice. The loess fitted curve is shown in blue and the induced Aire-dependent genes (fold change [FC] &gt; 5) in red. (<bold>G</bold>) Heatmap of significantly downregulated activation factors in mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice. (<bold>H</bold>) <italic>Aire</italic> and <italic>Fezf2</italic> mRNAs were measured by qPCR in mTEC<sup>lo</sup> from WT (n = 3–4) and mTEC<sup>ΔMHCII</sup> (n = 4) mice. (<bold>I</bold>) FC in the expression of HDAC3-induced transcriptional regulators and other transcription factors significantly upregulated in WT versus mTEC<sup>ΔMHCII</sup> mice. The color code represents gene expression level. (<bold>J</bold>) Heatmap of significantly downregulated cytokines, chemokines, and cell adhesion molecules in mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice. (<bold>K</bold>) Hierarchical clustering and heatmap of mean expression of these activation factors, cell adhesion molecules, chemokines, and cytokines in mTEC subsets identified by scRNA-seq. Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 using two-tailed Mann–Whitney test for (<bold>A</bold>), (<bold>E</bold>) and (<bold>H</bold>) and chi-squared test for (<bold>C</bold>) and (<bold>F</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Altered expression of some cytokines, cell adhesion molecules, and chemokines in mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice.</title><p><italic>Il21</italic>, <italic>Il5, Il15, Ccl22,</italic> and <italic>Icam2</italic> mRNAs were measured by qPCR in mTEC<sup>lo</sup> from WT (n = 4) and mTEC<sup>ΔMHCII</sup> (n = 3–4) mice. Error bars show mean ± SEM, *p&lt;0.05 using two-tailed Mann–Whitney test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig2-figsupp1-v2.tif"/></fig></fig-group><p>The comparison of the gene expression profiles of mTEC<sup>lo</sup> purified from WT and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) revealed that MHCII/TCR interactions with CD4<sup>+</sup> thymocytes resulted in the upregulation of 1300 genes (FC &gt; 2), 449 of them reaching statistical significance (Cuffdiff p&lt;0.05). 846 genes were also downregulated (FC &lt; 0.5) with 340 reaching significance (Cuffdiff p&lt;0.05) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Similarly to the comparison of WT versus ΔCD4 mice (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), the genes significantly upregulated by MHCII/TCR interactions in mTEC<sup>lo</sup> corresponded preferentially to TRAs (p=4.5 × 10<sup>–13</sup>) that are mainly Aire-dependent and Aire/Fezf2-independent (<xref ref-type="fig" rid="fig2">Figure 2C–E</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). In line with the recent discovery of <italic>Aire</italic> expression in mTECs expressing intermediate levels of CD80 identified in the proliferating and maturational stage mTEC single-cell clusters (<xref ref-type="bibr" rid="bib18">Dhalla et al., 2020</xref>), we found a strong correlation (p=2 × 10<sup>–16</sup>) between gene upregulation induced by MHCII/TCR interactions and the responsiveness of genes to Aire’s action obtained from the comparison between WT and <italic>Aire</italic><sup>-/-</sup> mTEC<sup>hi</sup> (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). These data are in agreement with the identification of a list of activation factors including <italic>Aire</italic> among the non-TRA genes induced by MHCII/TCR interactions with CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice expressed ~4.5-fold less <italic>Aire</italic> than WT mTEC<sup>lo</sup>, with substantial levels of 15.8 and 73.7 fragments per kilobase of transcript per million mapped reads (FPKM), respectively. For comparison, <italic>Aire</italic> expression level in WT mTEC<sup>hi</sup> was 448.9 FPKM. mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice also expressed ~1.5-fold less <italic>Fezf2</italic> than WT mTEC<sup>lo</sup> (90.2 versus 134.5 FPKM, respectively). This reduction in <italic>Aire</italic> and <italic>Fezf2</italic> expression in mTEC<sup>ΔMHCII</sup> mice was also confirmed by qPCR (<xref ref-type="fig" rid="fig2">Figure 2H</xref>). These results highlight the importance of MHCII/TCR interactions with CD4<sup>+</sup> thymocytes in upregulating <italic>Aire</italic> and <italic>Fezf2</italic> mRNAs and some of their associated TRAs in mTEC<sup>lo</sup>. Interestingly, 17 HDAC3-regulated transcription factors as well as <italic>Nfkb2</italic>, <italic>Trp53,</italic> and <italic>Relb</italic> transcription factors were induced by MHCII/TCR interactions with CD4<sup>+</sup> thymocytes (<xref ref-type="fig" rid="fig2">Figure 2I</xref>). Moreover, the expression of several cytokines, chemokines, and cell adhesion molecules was also upregulated (<xref ref-type="fig" rid="fig2">Figure 2J</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Using single-cell RNA-seq data (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>), we found that these genes were poorly associated with CCL21<sup>+</sup> and tuft-like mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). Consistently with the altered cellularity of Aire<sup>+</sup> mTECs in mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>), some of these genes were associated with post-Aire cells. Strikingly, many genes upregulated by CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup> were highly expressed by Aire<sup>+</sup> mTECs. Interestingly, several of these genes were already expressed by TAC-TECs, including <italic>Aire</italic> and <italic>Fezf2</italic>, strongly suggesting that an enhanced transcriptional activity promoted by MHCII/TCR interactions with CD4<sup>+</sup> thymocytes accompanies the transition from TAC-TECs to Aire<sup>+</sup> mTECs. Altogether, these data show that CD4<sup>+</sup> thymocytes, through MHCII/TCR interactions, control the functional properties of mTEC<sup>lo</sup> and activate key transcriptional programs governing their differentiation and function.</p></sec><sec id="s2-3"><title>TCR/MHCII interactions with CD4<sup>+</sup> thymocytes regulate the development of Fezf2<sup>+</sup> pre-Aire, post-Aire, and tuft-like mTEC subsets</title><p>Since key transcription factors implicated in mTEC differentiation were upregulated in mTEC<sup>lo</sup> by MHCII/TCR-mediated interactions with CD4<sup>+</sup> thymocytes (<xref ref-type="fig" rid="fig1">Figures 1G</xref> and <xref ref-type="fig" rid="fig2">2I</xref>), we next analyzed the composition for the newly identified mTEC subsets in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice. In agreement with our previous study (<xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>), we first observed a substantial reduction in the frequencies and numbers of mTEC<sup>hi</sup> in both mice (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Furthermore, numbers of mTEC<sup>lo</sup> were also substantially reduced. Consequently, ΔCD4 and mTEC<sup>ΔMHCII</sup> mice have a globally reduced cellularity in total mTECs. An Aire/Fezf2 co-staining both by histology and flow cytometry then revealed a substantial reduction in Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> cells (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). We further analyzed by flow cytometry Aire and Fezf2 expression specifically in mTEC<sup>lo</sup> and mTEC<sup>hi</sup>, according to the gating strategy shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>. In agreement with the detection of <italic>Aire</italic> in the proliferating and maturational single-cell clusters in mTEC<sup>lo</sup> (<xref ref-type="bibr" rid="bib7">Baran-Gale et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Dhalla et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>), we found that Aire protein was expressed in a small fraction of mTEC<sup>lo</sup> compared to mTEC<sup>hi</sup> in WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> mTECs were reduced in mTEC<sup>lo</sup> of ΔCD4 and mTEC<sup>ΔMHCII</sup> mice with a more marked effect in mTEC<sup>hi</sup>. This decrease was not due to impaired proliferation since normal frequencies of Ki-67<sup>+</sup> proliferating cells were observed in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Furthermore, numbers of involucrin<sup>+</sup>TPA<sup>+</sup>Aire<sup>-</sup> post-Aire cells were reduced in the medulla of ΔCD4 and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>), consistently with the decrease of Aire<sup>+</sup> mTEC<sup>hi</sup> (<xref ref-type="fig" rid="fig3">Figure 3B and C</xref>). In contrast, the frequencies of CCL21<sup>+</sup> cells among mTEC<sup>lo</sup> were not altered in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This is in line with the observation that few genes upregulated by TCR/MHCII interactions with CD4<sup>+</sup> thymocytes were associated with CCL21<sup>+</sup> mTECs (<xref ref-type="fig" rid="fig1">Figures 1I</xref> and <xref ref-type="fig" rid="fig2">2K</xref>). We also analyzed tuft-like mTECs since the expression of the transcription factor <italic>Pou2f3</italic>, known to control the development of this cell type (<xref ref-type="bibr" rid="bib10">Bornstein et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Miller et al., 2018</xref>), was decreased in mTEC<sup>lo</sup> of ΔCD4 and mTEC<sup>ΔMHCII</sup> mice (<xref ref-type="fig" rid="fig1">1</xref>,<xref ref-type="fig" rid="fig2">2</xref><xref ref-type="fig" rid="fig1">Figures 1G</xref> and <xref ref-type="fig" rid="fig2">2I</xref>). We found that numbers of tuft-like mTECs identified by flow cytometry using the DCLK1 marker were reduced in both mice (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>), indicating that their development is promoted by MHCII/TCR interactions with CD4<sup>+</sup> thymocytes. Importantly, Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> mTEC<sup>lo</sup> and mTEC<sup>hi</sup> as well as CCL21<sup>+</sup> and DCLK1<sup>+</sup> tuft-like mTEC<sup>lo</sup> were similarly reduced in MHCII<sup>-/-</sup> mice, further confirming that CD4<sup>+</sup> thymocytes control the cellularity of these novel mTEC subsets (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). Altogether, these data reveal that MHCII/TCR-mediated interactions with CD4<sup>+</sup> thymocytes have a broad impact on mTEC composition by controlling the cellularity of not only Aire<sup>+</sup>Fezf2<sup>+</sup> mTECs but also Fezf2<sup>+</sup> pre-Aire<sup>+</sup> mTECs, post-Aire, and tuft-like cells.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The composition in medullary thymic epithelial cell (mTEC) subsets is altered in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice.</title><p>(<bold>A</bold>) Flow cytometry profiles, frequencies, and numbers of mTEC<sup>lo</sup> and mTEC<sup>hi</sup> in WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice. Data are representative of 2–3 independent experiments (n = 2–5 mice per group and experiment). (<bold>B</bold>) Confocal images of thymic sections from WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice stained for Aire (green) and Fezf2 (red). 12 and 20 sections derived from two WT, two ΔCD4, and two mTEC<sup>ΔMHCII</sup> mice were quantified. Scale bar, 50 μm. Unfilled, dashed and solid arrowheads indicate Aire<sup>+</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells, respectively. The histogram shows the density of Aire<sup>+</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells. (<bold>C–E</bold>) Flow cytometry profiles, frequencies, and numbers of Aire<sup>-</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells in total mTECs, mTEC<sup>lo</sup>, and mTEC<sup>hi</sup> (<bold>C</bold>), of CCL21<sup>+</sup> cells in mTEC<sup>lo</sup> (<bold>D</bold>) and of DCKL1<sup>+</sup> cells in Aire<sup>-</sup> mTEC<sup>lo</sup> (<bold>E</bold>) from WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice. II Abs: secondary antibodies. Data are representative of 2–3 independent experiments (n = 2–5 mice per group and experiment). Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 using unpaired Student’s <italic>t</italic>-test for (<bold>B</bold>) and two-tailed Mann–Whitney test for (<bold>A</bold>) and (<bold>C</bold>-<bold>E</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Normal proliferation of Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire <sup>+</sup>Fezf2<sup>+</sup> medullary thymic epithelial cell (mTECs) in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice.</title><p>(<bold>A, B</bold>) Flow cytometry profiles and frequencies of Ki-67<sup>+</sup> proliferating Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> cells in mTEC<sup>lo</sup> (<bold>A</bold>) and mTEC<sup>hi</sup> (<bold>B</bold>) from WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice. Data are representative of two independent experiments (n = 3–4 mice per group and experiment). Error bars show mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Reduced post-Aire medullary thymic epithelial cells (mTECs) in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice.</title><p>(<bold>A</bold>) Representative thymic sections stained with antibodies against involucrin (red), TPA (green), and Aire (magenta). c and m denote the cortex and the medulla, respectively. The graph shows the number of involucrin<sup>+</sup>TPA<sup>+</sup>Aire<sup>-</sup> cells per medulla. 15 medullas derived from two WT, two ΔCD4, and two mTEC<sup>ΔMHCII</sup> mice were quantified, respectively. Scale bar: 200 μm. Error bars show mean ± SEM, **p&lt;0.01 using unpaired Student’s <italic>t</italic>-test. (<bold>B</bold>) Gating strategy used to identify Aire<sup>-</sup> mTEC<sup>lo</sup> cells in WT, ΔCD4, and mTEC<sup>ΔMHCII</sup> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Analysis of medullary thymic epithelial cell (mTEC) subsets in MHCII<sup>-/-</sup> mice.</title><p>(<bold>A</bold>) Flow cytometry profiles and numbers of Aire<sup>-</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells in total mTECs, mTEC<sup>lo</sup>, and mTEC<sup>hi</sup> from WT, ΔCD4, and MHCII<sup>-/-</sup> mice. II Abs: secondary antibodies. Data are representative of two independent experiments (n = 2–4 mice per group). (<bold>B</bold>) Flow cytometry profiles, frequencies, and numbers of CCL21<sup>+</sup> cells in mTEC<sup>lo</sup> from WT, ΔCD4, and MHCII<sup>-/-</sup> mice. (<bold>C</bold>) Flow cytometry profiles, frequencies, and numbers of DCKL1<sup>+</sup> cells in Aire<sup>-</sup> mTEC<sup>lo</sup>. Data are representative of two independent experiments (n = 2–3 mice per group). Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 using the Mann–Whitney test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig3-figsupp3-v2.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Highly self-reactive CD4<sup>+</sup> thymocytes activate maturational programs in mTEC<sup>lo</sup></title><p>We next assessed the impact of highly self-reactive interactions with CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup> using OTII-<italic>Rag2</italic><sup>-/-</sup> and RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> transgenic mice. Both models possess CD4<sup>+</sup> thymocytes expressing an MHCII-restricted TCR specific for the chicken ovalbumin (OVA). The Rip-mOVA line expresses a membrane-bound OVA form specifically in mTECs, and consequently high-affinity interactions between OVA-expressing mTECs and OTII CD4<sup>+</sup> thymocytes are only possible in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="bibr" rid="bib39">Kurts et al., 1996</xref>). In contrast to total Erk1/2 MAPK, p38 MAPK, IKKα, and p65, the nonclassical NF-kB subunit RelB was increased in mTEC<sup>lo</sup> at mRNA and protein levels in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). By reanalyzing single-cell RNA-seq data on mTEC<sup>lo</sup> subsets, we found that in contrast to CCL21<sup>+</sup> and tuft-like mTECs <italic>Relb</italic> is highly expressed by TAC-TECs and post-Aire cells, arguing again in favor that self-reactive CD4<sup>+</sup> thymocytes act from the TAC-TEC stage to induce their differentiation into Aire<sup>+</sup> cells and then into post-Aire cells (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2A</xref>). The level of RelB phosphorylation was also higher in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> than OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), suggesting that self-reactive CD4<sup>+</sup> thymocytes may activate the nonclassical NF-κB pathway in mTEC<sup>lo</sup>.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Highly self-reactive CD4<sup>+</sup> thymocytes control the transcriptional and functional properties of mTEC<sup>lo</sup>.</title><p>(<bold>A</bold>) <italic>Relb</italic> mRNA was measured by qPCR in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> (n = 4) and OTII-<italic>Rag2</italic><sup>-/-</sup> (n = 5) mice. (<bold>B</bold>) Total and phospho-RelB (Ser552) were analyzed by flow cytometry in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice. Data are representative of two independent experiments (n = 3–4 mice per group and experiment). (<bold>C</bold>) Scatter plot of gene expression levels (fragments per kilobase of transcript per million mapped reads [FPKM]) in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice. Genes with fold difference ≥2 and p-adj&lt;0.05 were considered as upregulated or downregulated genes (red and blue dots, respectively). RNA-seq was performed on two independent biological replicates with mTEC<sup>lo</sup> derived from 5 to 8 mice. (<bold>D</bold>) Numbers of tissue-restricted self-antigens (TRAs) and non-TRAs in genes up- and downregulated in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice. ND, not determined. (<bold>E</bold>) Numbers of induced Aire-dependent, Fezf2-dependent, Aire/Fezf2-dependent, and Aire/Fezf2-independent TRAs. (<bold>F</bold>) Aire-dependent (<italic>Fam183b, Nts</italic>), Fezf2-dependent (<italic>Resp18, Grap</italic>), Aire/Fezf2-dependent (<italic>Fabp9</italic>), Aire/Fezf2-independent (<italic>Csn2</italic>, <italic>Crp</italic>) TRAs, <italic>Aire</italic> and <italic>Fezf2</italic> mRNAs were measured by qPCR in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> (n = 4) and OTII-<italic>Rag2</italic><sup>-/-</sup> (n = 4) mice. (<bold>G</bold>) Scatter plot of gene expression variation in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice and in mTEC<sup>hi</sup> from WT versus <italic>Aire</italic><sup>-/-</sup> mice. The loess fitted curve is shown in blue and induced Aire-dependent genes (fold change [FC] &gt; 5) in red. (<bold>H</bold>) Heatmap of significantly upregulated activation factors in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice. (<bold>I, J</bold>) Expression FC in HDAC3-induced transcriptional regulators and other transcription factors (<bold>I</bold>) and in Foxn1 targets (<bold>J</bold>) in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice. The color code represents gene expression level. (<bold>K</bold>) Heatmap of significantly upregulated cytokines, chemokines, and cell adhesion molecules in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice. (<bold>L</bold>) Hierarchical clustering and heatmap of mean expression of these activation factors, cell adhesion molecules, chemokines, and cytokines in mTEC subsets identified by scRNA-seq. Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001 using two-tailed Mann–Whitney test for (<bold>A</bold>), (<bold>B</bold>) and (<bold>F</bold>) and chi-squared test for (<bold>D</bold>) and (<bold>G</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Similar levels of total and phosphorylated p65, Erk1/2, p38, and IKKα proteins in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice.</title><p>(<bold>A, B</bold>) Total p65, Erk1/2, p38, and IKKα (<bold>A</bold>) and phospho-p65 (Ser536), phospho-Erk1/2 MAPK (Thr202/Tyr204), phospho-p38 MAPK (Thr180/Tyr182), and phospho-IKKα(Ser180)/IKKβ(Ser181) (<bold>B</bold>) proteins were analyzed by flow cytometry in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice. Histograms show the MFI. (<bold>C</bold>) Histograms represent the ratio of phospho-p65 (Ser536) to p65, phospho-Erk1/2 MAPK (Thr202/Tyr204) to Erk1/2, phospho-p38 MAPK (Thr180/Tyr182) to p38, and phospho-IKKα (Ser180)/IKKβ(Ser181) to IKKα. II Abs: secondary antibodies. Data are representative of two independent experiments (n = 2–4 mice per group and experiment). Error bars show mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Expression of <italic>Relb</italic>, cytokines, chemokines, and cell adhesion molecules that was altered in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice.</title><p>(<bold>A</bold>) Mean expression of <italic>Relb</italic> in mTEC<sup>lo</sup> subsets identified by scRNA-seq data derived from <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>. (<bold>B</bold>) <italic>Il5</italic>, <italic>Il15, Il7, Ccl19, Ccl2, Ccl25, Cdh2,</italic> and <italic>Itgad</italic> mRNAs were measured by qPCR in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> (n = 3–4) and OTII-<italic>Rag2</italic><sup>-/-</sup> (n = 3–4) mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig4-figsupp2-v2.tif"/></fig></fig-group><p>To define the genome-wide effects of highly self-reactive CD4<sup>+</sup> thymocytes in mTEC<sup>lo</sup>, we compared the gene expression profiles of mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) and found an upregulation of 1438 genes (FC &gt; 2) reaching statistical significance for 522 of them (Cuffdiff p&lt;0.05). 620 genes were also downregulated (FC &lt; 0.5) with 136 reaching significance (Cuffdiff p&lt;0.05) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The genes upregulated exhibited an approximately fourfold more of TRA over non-TRA genes (p=4.7 × 10<sup>–23</sup>), which corresponded mainly to Aire-dependent and Aire/Fezf2-independent TRAs (<xref ref-type="fig" rid="fig4">Figure 4D–F</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Similarly to the WT versus mTEC<sup>ΔMHCII</sup> comparison, we found a strong correlation (p=6.2 × 10<sup>–7</sup>) between the genes upregulated by self-reactive CD4<sup>+</sup> thymocytes and the responsiveness of genes to Aire’s action obtained from the comparison between WT and <italic>Aire</italic><sup>-/-</sup> mTEC<sup>hi</sup> (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). These results support an impact of antigen-specific interactions in the expression of TRAs in mTEC<sup>lo</sup>, notably on Aire-dependent TRAs. Importantly, these results are in agreement with the induction of a list of activation factors including <italic>Aire</italic> and <italic>Fezf2</italic> among the non-TRA genes (<xref ref-type="fig" rid="fig4">Figure 4H</xref>). Similarly to the comparisons of the WT versus ΔCD4 or mTEC<sup>ΔMHCII</sup> mice, numerous HDAC3-induced regulators as well as <italic>Sirt1</italic>, <italic>Nfkb2</italic>, <italic>Relb,</italic> and <italic>Trp53</italic> transcription factors were upregulated in mTEC<sup>lo</sup> of RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig4">Figure 4I</xref>). Interestingly, 21 out of 30 top targets of the Foxn1 transcription factor, implicated in TEC differentiation and growth (<xref ref-type="bibr" rid="bib79">Žuklys et al., 2016</xref>), as well as cytokines, chemokines, and cell adhesion molecules, were also upregulated (<xref ref-type="fig" rid="fig4">Figure 4J</xref>, K <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2B</xref>). We found that few of these genes were associated with CCL21<sup>+</sup> and tuft-like mTECs (<xref ref-type="fig" rid="fig4">Figure 4L</xref>). In contrast, many genes encoding for activation factors, cytokines, chemokines, and cell adhesion molecules were associated with Aire<sup>+</sup> and post-Aire mTECs, consistently with the fact that antigen-specific interactions with CD4<sup>+</sup> thymocytes control the cellularity of Aire<sup>+</sup> mTECs. Moreover, most of these genes, including <italic>Aire</italic> and <italic>Fezf2</italic>, were already expressed by TAC-TECs, further highlighting that CD4<sup>+</sup> thymocytes act upstream of Aire<sup>+</sup> mTEC<sup>hi</sup>. Altogether, these data reveal that highly self-reactive CD4<sup>+</sup> thymocytes control in mTEC<sup>lo</sup> not only key transcription factors driven by their differentiation but also key molecules for T-cell development and selection such as TRAs, cytokines, chemokines, and adhesion molecules.</p></sec><sec id="s2-5"><title>Highly self-reactive CD4<sup>+</sup> thymocytes control mTEC subset composition from a progenitor stage</title><p>Given that highly self-reactive CD4<sup>+</sup> thymocytes induce key transcription factors in mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig4">Figure 4H and I</xref>), we examined their respective impact on mTEC subset development. Strikingly, numbers of total TECs and mTECs were higher in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> than in OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). We analyzed four TEC subsets based on MHCII and UEA-1 levels, as previously described (<xref ref-type="bibr" rid="bib46">Lopes et al., 2017</xref>; <xref ref-type="bibr" rid="bib73">Wong et al., 2014</xref>; <xref ref-type="fig" rid="fig5">Figure 5C</xref>). In contrast to cTEC<sup>hi</sup> (MHCII<sup>hi</sup>UEA-1<sup>lo</sup>), numbers of TEC<sup>lo</sup> (MHCII<sup>lo</sup>UEA-1<sup>lo</sup>), mTEC<sup>lo</sup> (MHCII<sup>lo</sup>UEA-1<sup>+</sup>), and mTEC<sup>hi</sup> (MHCII<sup>hi</sup>UEA-1<sup>+</sup>) were higher in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> than in OTII-<italic>Rag2</italic><sup>-/-</sup> mice. Consistently, numbers of mTEC<sup>lo</sup> and mTEC<sup>hi</sup> identified based on the level of CD80 expression were also higher in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Interestingly, numbers of α6-integrin<sup>hi</sup>Sca-1<sup>hi</sup> thymic epithelial progenitor (TEPC)-enriched cells in the TEC<sup>lo</sup> subset were also increased (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), indicating that self-reactive CD4<sup>+</sup> thymocytes control TEC development from a progenitor stage. Of note, this strategy of TEC identification was not possible in ΔCD4 and mTEC<sup>ΔMHCII</sup> mice since MHCII expression is abrogated in TECs of these mice (<xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Highly self-reactive CD4<sup>+</sup> thymocytes control medullary thymic epithelial cell (mTEC) development from an early progenitor stage.</title><p>(<bold>A–D</bold>) Flow cytometry profiles and numbers of total thymic epithelial cells (TECs) (EpCAM<sup>+</sup>) (<bold>A</bold>), cortical thymic epithelial cell (cTECs) (UEA-1<sup>-</sup>Ly51<sup>hi</sup>), mTECs (UEA-1<sup>+</sup>Ly51<sup>lo</sup>) (<bold>B</bold>), TEC<sup>lo</sup> (MHCII<sup>lo</sup>UEA-1<sup>lo</sup>), cTEC<sup>hi</sup> (MHCII<sup>hi</sup>UEA-1<sup>lo</sup>), mTEC<sup>lo</sup> (MHCII<sup>lo</sup>UEA-1<sup>hi</sup>), and mTEC<sup>hi</sup> (MHCII<sup>hi</sup>UEA-1<sup>hi</sup>) (<bold>C</bold>), α6-integrin<sup>hi</sup>Sca-1<sup>hi</sup> TEPC-enriched cells in TEC<sup>lo</sup> (<bold>D</bold>) in CD45<sup>neg</sup>-enriched cells from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice. Data are representative of four experiments (n = 3 mice per group and experiment). (<bold>E</bold>) Confocal images of thymic sections from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice stained for Aire (green) and Fezf2 (red). 11 and 22 sections derived from two RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice were quantified, respectively. Scale bar, 50 μm. Unfilled, dashed and solid arrowheads indicate Aire<sup>+</sup>Fezf2<sup>lo</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells, respectively. The histogram shows the density of Aire<sup>+</sup>Fezf2<sup>lo</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells. (<bold>F–H</bold>) Flow cytometry profiles, frequencies, and numbers of Aire<sup>-</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells in total mTECs, mTEC<sup>lo</sup>, and mTEC<sup>hi</sup> (<bold>F</bold>), of CCL21<sup>+</sup> cells in mTEC<sup>lo</sup> (<bold>G</bold>) and of DCKL1<sup>+</sup> cells in Aire<sup>-</sup> mTECs (<bold>H</bold>) from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice. II Abs: secondary antibodies. Data are representative of two independent experiments (n = 3–4 mice per group and experiment). Error bars show mean ± SEM, *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 using unpaired Student’s <italic>t</italic>-test for (<bold>A–E</bold>) and two-tailed Mann–Whitney test for (<bold>F–H</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>mTEC<sup>lo</sup> and mTEC<sup>hi</sup> cells are increased in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice.</title><p>Flow cytometry profiles, frequencies, and numbers of mTEC<sup>lo</sup> and mTEC<sup>hi</sup> from RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice. Data are representative of two independent experiments (n = 3 mice per group and experiment). Error bars show mean ± SEM. **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001 using the Mann–Whitney test.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>The proliferation of Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> medullary thymic epithelial cells (mTECs) is similar in RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice.</title><p>(<bold>A, B</bold>) Flow cytometry profiles and frequencies of proliferating Ki-67<sup>+</sup> Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> in mTEC<sup>lo</sup> (<bold>A</bold>) and mTEC<sup>hi</sup> (<bold>B</bold>) from RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice. Data are representative of two independent experiments (n = 3 mice per group and experiment). Error bars show mean ± SEM.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Post-Aire medullary thymic epithelial cells (mTECs) are increased in RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> compared to OTII-<italic>Rag2<sup>-/-</sup></italic> mice.</title><p>(<bold>A</bold>) Representative thymic sections from RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice stained with antibodies against involucrin (red), TPA (green), and Aire (magenta). c and m denote the cortex and the medulla, respectively. The graph shows the number of involucrin<sup>+</sup>TPA<sup>+</sup>Aire<sup>-</sup> cells per medulla. 15 medullas derived from two RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and two OTII-<italic>Rag2<sup>-/-</sup></italic> mice were quantified, respectively. Scale bar: 200 μm. Error bars show mean ± SEM, ****p&lt;0.0001 using unpaired Student’s <italic>t</italic>-test. (<bold>B</bold>) Gating strategy used to identify Aire<sup>-</sup> mTEC<sup>lo</sup> cells in RipmOVAxOTII-<italic>Rag2<sup>-/-</sup></italic> and OTII-<italic>Rag2<sup>-/-</sup></italic> mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig5-figsupp3-v2.tif"/></fig></fig-group><p>A higher density of Aire<sup>+</sup>Fezf2<sup>-</sup>, Aire<sup>-</sup>Fezf2<sup>+</sup>, and Aire<sup>+</sup>Fezf2<sup>+</sup> cells was observed in medullary regions of RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice by immunohistochemistry (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Furthermore, numbers of Aire<sup>-</sup>Fezf2<sup>-</sup> mTEC<sup>lo</sup> analyzed by flow cytometry were also higher in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice, confirming that self-reactive CD4<sup>+</sup> thymocytes control mTEC differentiation from an early stage (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Numbers of Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> mTEC<sup>lo</sup> and mTEC<sup>hi</sup> were also markedly increased in these mice, although similar frequencies of proliferating Ki-67<sup>+</sup> cells were observed (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). In agreement with increased Aire<sup>+</sup> mTECs, involucrin<sup>+</sup>TPA<sup>+</sup>Aire<sup>-</sup> post-Aire cells were enhanced (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Furthermore, numbers of CCL21<sup>+</sup> and DCLK1<sup>+</sup> tuft-like cells in mTEC<sup>lo</sup> were also increased in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). These observations are consistent with our previous findings that antigen-specific interactions between mTECs and CD4<sup>+</sup> thymocytes induce medulla development (<xref ref-type="bibr" rid="bib31">Irla et al., 2012</xref>). Altogether, these results demonstrate that highly self-reactive CD4<sup>+</sup> thymocytes regulate mTECs from an early to a late developmental stage and thus mTEC composition.</p></sec><sec id="s2-6"><title>Self-reactive CD4<sup>+</sup> thymocytes enhance the level of active H3K4me3 mark in mTEC<sup>lo</sup></title><p>Since histone modifications constitute important regulatory mechanisms that control the open and closed states of mTEC chromatin (<xref ref-type="bibr" rid="bib67">Ucar and Rattay, 2015</xref>), we investigated whether self-reactive CD4<sup>+</sup> thymocytes induce histone modifications in mTECs. We first analyzed in WT mTEC<sup>lo</sup> the repressive H3K27me3 and the active H3K4me3 marks using chromatin immunoprecipitation (ChIP) followed by high-throughput sequencing (ChIP-seq). As expected, metagene analyses showed that Aire-dependent TRAs had higher levels of H3K27me3 in their genes than in all genes of the genome, confirming that they are in a repressive state (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). In contrast, Fezf2-dependent TRAs had a significant enrichment of H3K4me3 in their transcriptional start site (TSS) (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). Similarly, Aire/Fezf2-independent TRAs were associated with low levels of H3K27me3 in their genes and high levels of H3K4me3 in their TSS. Thus, in contrast to Aire-dependent TRAs that are associated with the repressive H3K27me3 histone mark, Fezf2-dependent and Aire/Fezf2-independent TRAs are associated with the active H3K4me3 mark, indicating that these distinct TRAs are subjected to a specific epigenetic regulation.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>H3K27me3 and H3K4me3 landscape in tissue-restricted self-antigen (TRA) genes of mTEC<sup>lo</sup> from WT, RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup>, and OTII-<italic>Rag2</italic><sup>-/-</sup> mice.</title><p>(<bold>A, B</bold>) Metagene profiles of the average normalized enrichment of H3K27me3 (<bold>A</bold>) and H3K4me3 (<bold>B</bold>) against input for Aire-dependent, Fezf2-dependent, and Aire/Fezf2-independent TRAs as well as for all genes of WT mTEC<sup>lo</sup>. Boxplots represent the median enrichment, the 95% CI of the median (notches), and the 75th and 25th percentiles of H3K27me3 and H3K4me3. (<bold>C</bold>) H3K27me3 and H3K4me3 levels were analyzed by flow cytometry in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> (n = 4) and OTII-<italic>Rag2</italic><sup>-/-</sup> (n = 5) mice. Histograms show the MFI. (<bold>D</bold>) Boxplots represent the median enrichment of H3K27me3 and H3K4me3 of Aire-dependent, Fezf2-dependent, and Aire/Fezf2-independent TRAs and in all genes of mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice. (<bold>E</bold>) Expression (RNA-seq) and H3K27me3 and H3K4me3 chromatin state (ChIP-seq) of the Aire/Fezf2-independent TRA, <italic>E2f2</italic>, in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice. *p&lt;0.05, **p&lt;10<sup>–3</sup>, ***p&lt;10<sup>–7</sup>, using the Mann–Whitney test for (<bold>A</bold>) and<bold> </bold>(<bold>B</bold>) and unpaired Student’s <italic>t</italic>-test for (<bold>C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig6-v2.tif"/></fig><p>We next assessed whether highly self-reactive CD4<sup>+</sup> thymocytes control the H3K27me3 and H3K4me3 chromatin landscape in mTEC<sup>lo</sup>. In contrast to H3K27me3, we found an increased global level of H3K4me3 in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice by flow cytometry (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We further analyzed by nano-ChIP-seq whether self-reactive CD4<sup>+</sup> thymocytes regulate in mTEC<sup>lo</sup> the level of these two histone marks in Aire-dependent, Fezf2-dependent, and Aire/Fezf2-independent TRA genes. H3K27me3 levels in Aire-dependent TRA genes were comparable in mTEC<sup>lo</sup> from RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, left panel). Although lower, H3K27me3 levels in Fezf2-dependent and Aire/Fezf2-independent TRAs as well as in all genes were similar in both mice, indicating that the interactions with self-reactive CD4<sup>+</sup> thymocytes do not regulate this repressive mark in TRA genes (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, left panel). In contrast, H3K4me3 global level was increased in the TSS of all TRAs in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> compared to OTII-<italic>Rag2</italic><sup>-/-</sup> mice as well as in all genes (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, right panel). For representation, whereas the Aire/Fezf2-independent TRA, E2F transcription factor 2 (<italic>E2f2</italic>) induced by these interactions, was barely devoid of H3K27me3 in both mice, it was marked by H3K4me3 in its TSS specifically in RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). These results thus show that self-reactive CD4<sup>+</sup> thymocytes enhance the global level of the active H3K4me3 histone mark in mTEC<sup>lo</sup> and in particular in the TSS of Fezf2-dependent and Aire/Fezf2-independent TRAs, indicative of an epigenetic regulation for their expression.</p></sec><sec id="s2-7"><title>MHCII/TCR interactions between mTECs and CD4<sup>+</sup> thymocytes prevent the development of autoimmunity</title><p>We next evaluated the impact of mTEC-CD4<sup>+</sup> thymocyte interactions on the generation of self-tolerant T cells by taking advantage that CD4<sup>+</sup> and CD8<sup>+</sup> T cells develop in mTEC<sup>ΔMHCII</sup> mice, in which MHCII/TCR interactions between mTECs and CD4<sup>+</sup> thymocytes are abrogated. Interestingly, since TRAs induced by MHCII/TCR interactions showed a diverse peripheral tissue distribution in mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>), we analyzed the TCRVβ usage in mTEC<sup>ΔMHCII</sup> mice by flow cytometry. TCRVβ usage was more altered in CD69<sup>-</sup> mature CD4<sup>+</sup> thymocytes than in CD8<sup>+</sup> thymocytes (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). Some TCRVβ were also altered in splenic CD4<sup>+</sup> and CD8<sup>+</sup> T cells. To determine whether these T cells contained self-reactive specificities, we adoptively transferred splenocytes from mTEC<sup>ΔMHCII</sup> or WT mice into lymphopenic <italic>Rag2</italic><sup>-/-</sup> recipients (<xref ref-type="fig" rid="fig7">Figure 7C</xref>). Mice that received splenocytes derived from mTEC<sup>ΔMHCII</sup> mice lost significantly more weight than mice transferred with WT splenocytes (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). They also exhibited splenomegaly with increased follicle areas and T-cell numbers showing a CD62L<sup>lo</sup>CD44<sup>hi</sup> effector and CD62L<sup>hi</sup>CD44<sup>hi</sup> central memory phenotype (<xref ref-type="fig" rid="fig7">Figure 7E–G</xref>). Immune infiltrates in lungs and salivary glands were observed by histology and flow cytometry in 75 and 41% of mice, respectively (<xref ref-type="fig" rid="fig7">Figure 7H and I</xref>). These two tissues contained increased numbers of central memory as well as CD44<sup>+</sup>CD69<sup>+</sup> and CD44<sup>+</sup>CD69<sup>-</sup> activated CD4<sup>+</sup> and CD8<sup>+</sup> T cells (<xref ref-type="fig" rid="fig7">Figure 7J</xref>). T-cell infiltrates were also observed in other tissues such as kidney, liver, and colon in agreement with the defective TRA expression associated with these tissues (<xref ref-type="fig" rid="fig7">Figure 7A and K</xref>). Altogether, these data show that in the absence of MHCII/TCR interactions between mTECs and CD4<sup>+</sup> thymocytes, T cells contained self-reactive specificities and thus that these interactions are critical to the establishment of T-cell tolerance.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The adoptive transfer of T cells from mTEC<sup>ΔMHCII</sup> mice into <italic>Rag2</italic><sup>-/-</sup> recipients induces autoimmunity.</title><p>(<bold>A</bold>) Tissue-restricted self-antigens (TRAs) underexpressed in mTEC<sup>lo</sup> from mTEC<sup>ΔMHCII</sup> mice were assigned to their peripheral expression. (<bold>B</bold>) TCRVβ usage by CD69<sup>-</sup> mature CD4<sup>+</sup> and CD8<sup>+</sup> thymocytes (left panel) and CD4<sup>+</sup>Foxp3<sup>-</sup> and CD8<sup>+</sup> splenic T cells (right panel) from WT and mTEC<sup>ΔMHCII</sup> mice. (<bold>C</bold>) Body weight of <italic>Rag2</italic><sup>-/-</sup> recipients transferred with splenic T cells from WT or mTEC<sup>ΔMHCII</sup> was monitored during 6 weeks, and tissue infiltration was examined. (<bold>D</bold>) Weight loss relative to the initial weight. (<bold>E, F</bold>) Representative spleen pictures and their weights (<bold>E</bold>) and hematoxylin/eosin counterstained splenic sections (<bold>F</bold>). Scale bar, 1 mm. The histogram shows follicle areas. (<bold>G</bold>) Numbers of splenic CD3<sup>+</sup>, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells and of naive (CD44<sup>lo</sup>CD62L<sup>hi</sup>), effector memory (EM; CD44<sup>hi</sup>CD62L<sup>lo</sup>) and central memory (CM; CD44<sup>hi</sup>CD62L<sup>hi</sup>) phenotype. (<bold>H</bold>) Lung and salivary gland (SG) immune infiltrates detected by hematoxylin/eosin counterstaining. Scale bar, 1 mm. (<bold>I, J</bold>) Numbers of T cells (<bold>I</bold>) and of naive, effector and central memory phenotype as well as CD44<sup>+</sup>CD69<sup>+</sup> and CD44<sup>+</sup>CD69<sup>-</sup> T cells (<bold>J</bold>) in lungs and SG. (<bold>K</bold>) Schematic of T-cell infiltrates in mice transferred with mTEC<sup>ΔMHCII</sup> T cells relative to those transferred with WT T cells. Each circle and black triangles represent an individual mouse and T-cell infiltration in a specific tissue, respectively. Data are representative of two independent experiments (n = 5–7 mice per group and experiment). Error bars show mean ± SEM, ****p&lt;0.0001 using two-way ANOVA for (<bold>D</bold>) and unpaired Student’s <italic>t</italic>-test for (<bold>B</bold>) and (<bold>E</bold>-<bold>J</bold>). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>CD4<sup>+</sup> thymocytes through MHCII/TCR-mediated interactions control transcriptional programs of mTEC<sup>lo</sup> that drive their differentiation and function.</title><p>Antigen-specific interactions between CD4<sup>+</sup> thymocytes and mTEC<sup>lo</sup> lead to the upregulation of tissue-restricted self-antigen (TRA) regulators, TRAs, key medullary thymic epithelial cell (mTEC)-specific transcription factors, adhesion molecules, cytokines, and chemokines, which correlates with an increased level of the active H3K4me3 histone mark. These interactions enhance the transcriptional activity of TAC-TECs accompanying the transition to Aire<sup>+</sup>Fezf2<sup>+</sup>, as well as post-Aire cells and tuft-like mTECs. They are thus essential to generate a self-tolerant T-cell repertoire and prevent the development of autoimmunity.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-fig7-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Since mTECs play a crucial role in immunological tolerance by their exclusive expression of TRAs, it is essential to deepen our knowledge of the mechanisms that sustain their differentiation. Here using three distinct transgenic models, we found that self-reactive CD4<sup>+</sup> thymocytes control the developmental transcriptional programs from the mTEC<sup>lo</sup> stage, including TAC-TECs that precede Aire<sup>+</sup> mTECs. CD4<sup>+</sup> thymocytes increase in mTEC<sup>lo</sup> the phosphorylation of p38 MAPK and IKKα, the latter implicated in mTEC development (<xref ref-type="bibr" rid="bib44">Lomada et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Shen et al., 2019</xref>). Moreover, self-reactive CD4<sup>+</sup> thymocytes increase RelB phosphorylation level. Interestingly, this nonclassical NF-κB subunit is crucial for mTEC differentiation and Aire-dependent and -independent TRA expression (<xref ref-type="bibr" rid="bib56">Riemann et al., 2017</xref>). These data thus suggest that CD4<sup>+</sup> thymocytes activate intracellular pathways from the mTEC<sup>lo</sup> stage, although alterations in mTEC<sup>lo</sup> subset composition could also contribute to the differences observed. Nevertheless, the substantial and homogeneous reduction in the levels of phospho-IKKα, -p38, and -RelB argues instead for impaired activation of IKKα, p38, and RelB signaling in the absence of self-reactive CD4<sup>+</sup> thymocytes. Analysis of the mTEC<sup>lo</sup> transcriptional landscape by high-throughput RNA-seq revealed that self-reactive CD4<sup>+</sup> thymocytes upregulate <italic>Nfkb2</italic> (p52), known to form an heterocomplex with RelB in the nucleus upon activation (<xref ref-type="bibr" rid="bib30">Irla et al., 2010</xref>). p52 is important for mTEC development, Aire, and TRA expression (<xref ref-type="bibr" rid="bib76">Zhang et al., 2006</xref>; <xref ref-type="bibr" rid="bib78">Zhu et al., 2006</xref>). Consequently, ΔCD4, mTEC<sup>ΔMHCII</sup>, and OTII-<italic>Rag2</italic><sup>-/-</sup> mice in which MHCII/TCR interactions between mTECs and CD4<sup>+</sup> thymocytes are disrupted have altered <italic>Relb</italic> and <italic>Nfkb2</italic> expression, and reduced Aire<sup>+</sup> mTEC numbers and Aire-dependent TRA representation. Our results are in agreement with the fact that RANK-induced NF-κB signaling is activated by membrane-bound RANKL and not soluble RANKL and thereby in the context of physical interactions between mTECs and CD4<sup>+</sup> thymocytes (<xref ref-type="bibr" rid="bib5">Asano et al., 2019</xref>).</p><p>These interactions also upregulate <italic>Trp53</italic> (p53) that controls the mTEC niche (<xref ref-type="bibr" rid="bib58">Rodrigues et al., 2017</xref>) and <italic>Irf4</italic> and <italic>Irf7</italic> transcription factors that regulate key chemokines implicated in thymocyte medullary localization and mTEC differentiation (<xref ref-type="bibr" rid="bib24">Haljasorg et al., 2017</xref>; <xref ref-type="bibr" rid="bib54">Otero et al., 2013</xref>). Furthermore, the deacetylase Sirtuin-1 (<italic>Sirt1</italic>), which regulates Aire activity (<xref ref-type="bibr" rid="bib13">Chuprin et al., 2015</xref>), and <italic>Spib,</italic> which limits mTEC differentiation (<xref ref-type="bibr" rid="bib3">Akiyama et al., 2014</xref>), were also upregulated. Self-reactive CD4<sup>+</sup> thymocytes thus induce key transcription factors that both positively and negatively control mTEC differentiation. Remarkably, our three different transgenic models revealed that CD4<sup>+</sup> thymocytes induce HDAC3-dependent mTEC-specific transcription factors (<xref ref-type="bibr" rid="bib21">Goldfarb et al., 2016</xref>). Among them, <italic>Pou2f3</italic> is involved in tuft-like mTEC development (<xref ref-type="bibr" rid="bib10">Bornstein et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Miller et al., 2018</xref>), which is consistent with our results showing that self-reactive CD4<sup>+</sup> thymocytes control the cellularity of these cells. Our data thus identify that CD4<sup>+</sup> thymocytes control the expression of master transcriptional regulators of mTEC differentiation and function.</p><p>In line with these data, we found that self-reactive CD4<sup>+</sup> thymocytes regulate TEC development from a progenitor stage since they increase numbers of TEPC-enriched cells that express non-negligible MHCII levels. Interestingly, we provide the first evidence that self-reactive CD4<sup>+</sup> thymocytes control the cellularity of Fezf2<sup>+</sup> mTECs. Accordingly, the expression of Fezf2 and its respective TRAs was enhanced by CD4<sup>+</sup> thymocytes. Moreover, self-reactive CD4<sup>+</sup> thymocytes regulate the cellularity of CCL21<sup>+</sup>, post-Aire, and tuft-like cells in mTEC<sup>lo</sup>. These results are in full agreement with our previous findings that self-reactive thymocytes drive medulla expansion and increase the overall cellularity of the mTEC compartment (<xref ref-type="bibr" rid="bib31">Irla et al., 2012</xref>). Because the heterogeneous composition in mTEC<sup>lo</sup> could influence the expression of the upregulated genes by self-reactive CD4<sup>+</sup> thymocytes, we reanalyzed single-cell RNA-seq data in order to define their respective expression pattern in mTEC subsets. In accordance with the moderately altered frequencies of CCL21<sup>+</sup> cells among mTEC<sup>lo</sup> observed by flow cytometry, few genes upregulated by self-reactive CD4<sup>+</sup> thymocytes were associated with this mTEC subset. In contrast, we found that antigen-specific interactions with CD4<sup>+</sup> thymocytes strongly upregulate genes associated with TAC-TECs, Aire<sup>+</sup> mTECs, and post-Aire cells. These findings indicate that self-reactive CD4<sup>+</sup> thymocytes act from the precursors of Aire<sup>+</sup> mTEC<sup>hi</sup> (i.e., in TAC-TECs) to the post-Aire stage. It is interesting to note that although strongly altered the development of mTEC<sup>hi</sup> is not completely abrogated in the absence of CD4<sup>+</sup> thymocytes or MHCII/TCR-mediated interactions with CD4<sup>+</sup> thymocytes. This could be explained by the fact that invariant NKT have been proposed to participate in mTEC differentiation by expressing RANKL (<xref ref-type="bibr" rid="bib72">White et al., 2014</xref>). Overall, our results thus reveal that antigen-specific interactions with CD4<sup>+</sup> thymocytes have an unsuspected broad impact on mTEC composition by driving their development from an early progenitor to a late post-Aire stage.</p><p>Interestingly, high-throughput RNA-seq showed that MHCII/TCR interactions with CD4<sup>+</sup> thymocytes upregulate the expression of chemokines in mTEC<sup>lo</sup>. Among them, CCL19 (CCR7 ligand) is implicated in the medullary localization of thymocytes and the emigration of newly generated T cells (<xref ref-type="bibr" rid="bib68">Ueno et al., 2004</xref>); and CCL22 (CCR4 ligand) implicated in medullary entry and thymocyte/dendritic cell interactions (<xref ref-type="bibr" rid="bib28">Hu et al., 2015</xref>). Self-reactive CD4<sup>+</sup> thymocytes also enhance CCL2 (CCR2 ligand) and CCL20 (CCR6 ligand) that promote the entry of peripheral dendritic cells and Foxp3<sup>+</sup> regulatory T cells into the thymus (<xref ref-type="bibr" rid="bib6">Baba et al., 2009</xref>; <xref ref-type="bibr" rid="bib12">Cédile et al., 2014</xref>; <xref ref-type="bibr" rid="bib14">Cowan et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Lopes et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Borelli and Irla, 2021</xref>). mTEC-CD4<sup>+</sup> thymocyte interactions thus induce key chemokines that regulate the trafficking of thymocytes and dendritic cells that participate in tolerance induction. Moreover, cytokines such as <italic>Il15</italic> and <italic>Fgf21</italic> implicated in invariant NKT development and TEC protection against senescence, as well as adhesion molecules involved in mTEC-thymocyte interactions, were also induced (<xref ref-type="bibr" rid="bib55">Pezzi et al., 2016</xref>; <xref ref-type="bibr" rid="bib72">White et al., 2014</xref>; <xref ref-type="bibr" rid="bib74">Youm et al., 2016</xref>). Altogether, our data show that self-reactive CD4<sup>+</sup> thymocytes regulate functional properties of mTECs by inducing chemokines, cytokines, and adhesion molecules that are critical for T-cell development.</p><p>The expression of TRAs is regulated by Aire and to a lesser extent by Fezf2 (<xref ref-type="bibr" rid="bib4">Anderson et al., 2002</xref>; <xref ref-type="bibr" rid="bib64">Takaba et al., 2015</xref>). In agreement with other studies (<xref ref-type="bibr" rid="bib23">Gray et al., 2007</xref>; <xref ref-type="bibr" rid="bib64">Takaba et al., 2015</xref>), we found Fezf2 in both mTEC<sup>lo</sup> and mTEC<sup>hi</sup>, whereas Aire protein is mainly expressed in mTEC<sup>hi</sup>. Nevertheless and in line with recent single-cell transcriptomic analyses (<xref ref-type="bibr" rid="bib7">Baran-Gale et al., 2020</xref>; <xref ref-type="bibr" rid="bib18">Dhalla et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref>), we detected Aire by flow cytometry, qPCR, and RNA-seq in a small subset (~1.5%) of mTEC<sup>lo</sup>. CD4<sup>+</sup> thymocyte interactions upregulate <italic>Aire</italic> and <italic>Fezf2</italic> and some of their respective TRAs in these cells. Interestingly, in contrast to Aire-dependent TRAs that are characterized by high levels of H3K27me3 (<xref ref-type="bibr" rid="bib25">Handel et al., 2018</xref>; <xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>), we found that Fezf2-dependent TRAs show high levels of H3K4me3. This highlights that Aire and Fezf2 use distinct epigenetic modes in regulating TRA expression. Remarkably, these interactions also induce in mTEC<sup>lo</sup> numerous Aire/Fezf2-independent TRAs, whose regulation remains unknown. Similarly to Fezf2-dependent TRAs, they had high levels of H3K4me3 in their TSS, suggesting that Aire/Fezf2-independent TRAs are not subjected to the same regulatory transcriptional mechanisms than Aire-dependent TRAs. Our results are consistent with a previous study indicating that the Aire-independent TRA, <italic>Gad1</italic>, shows active epigenetic marks (<xref ref-type="bibr" rid="bib66">Tykocinski et al., 2010</xref>). Remarkably, self-reactive CD4<sup>+</sup> thymocytes increase H3K4me3 level in the TSS of all TRA categories, thus providing a novel epigenetic mechanistic insight into how they regulate the mTEC gene expression profile. In line with TRA regulation and the development of distinct mTEC subsets, the repertoire of mature T cells contains autoreactive cells when MHCII/TCR interactions were abrogated between mTECs and CD4<sup>+</sup> thymocytes. Accordingly, the adoptive transfer of splenocytes from mTEC<sup>ΔMHCII</sup> mice is capable of inducing signs of autoimmunity, illustrating the fact that mTEC-CD4<sup>+</sup> thymocyte interactions are critical for the generation of a self-tolerant T-cell repertoire. Future investigations based on TCR sequencing analysis are expected to define to which extent the TCR repertoire is altered in mTEC<sup>ΔMHCII</sup> mice.</p><p>In summary, our genome-wide scale study reveals that self-reactive CD4<sup>+</sup> thymocytes activate transcriptional programs from the TAC-TEC stage that sustains the differentiation into Aire<sup>+</sup>Fezf2<sup>+</sup> and post-Aire mTECs (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). These interactions also upregulate the expression of TRAs, cytokines, chemokines, and adhesion molecules that are all implicated in mTEC function. Thus, CD4<sup>+</sup> thymocytes control several unsuspected aspects of mTEC<sup>lo</sup> required for the establishment of T-cell tolerance.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6J background</td><td align="left" valign="bottom">Charles River</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Ciita</italic><sup>tm2Wrth</sup><italic>/Ciita</italic><sup>tm2Wrth</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib42">LeibundGut-Landmann et al., 2004</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:3052466">MGI:3052466</ext-link></td><td align="left" valign="bottom">C57BL/6 background, ΔCD4 mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">H2<sup>dlAb1-Ea</sup>/H2<sup>dlAb1-Ea</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib48">Madsen et al., 1999</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:4436873">MGI:4436873</ext-link></td><td align="left" valign="bottom">C57BL/6 background, MHCII<sup>-/-</sup> mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">K14x<italic>Ciita</italic><sup>III+IV-/-</sup></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom">C57BL/6 background, mTEC<sup>ΔMHCII</sup> mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Tg(TcraTcrb)425Cbn</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib8">Barnden et al., 1998</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:3762632">MGI:3762632</ext-link></td><td align="left" valign="bottom">C57BL/6 background, OTII mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom">Tg(Ins2-TFRC/OVA)296Wehi</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib39">Kurts et al., 1996</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:3623748">MGI:3623748</ext-link></td><td align="left" valign="bottom">C57BL/6 background, Rip-mOVA mice</td></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"><italic>Rag2<sup>tm1Fwa</sup>/Rag2<sup>tm1Fwa</sup></italic></td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib63">Shinkai et al., 1992</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:MGI:2174910">MGI:2174910</ext-link></td><td align="left" valign="bottom">C57BL/6 background, <italic>Rag2</italic><sup>-/-</sup> mice</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-IKKα (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2682; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331626">AB_331626</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho IKKα (Ser180)/IKKβ(Ser181) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2681S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331624">AB_331624</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-p38 MAPK (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9212; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330713">AB_330713</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho p38 MAPK (Thr180/Tyr182) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9211S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331641">AB_331641</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Erk1/2(rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9102; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_330744">AB_330744</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho Erk1/2 (Thr202/Tyr204) (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9101S;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331646">AB_331646</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-NF-κB p65 (clone D14E12, rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 8242S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10859369">AB_10859369</ext-link></td><td align="left" valign="bottom">FACS (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Phospho-NF-κB p65 (Ser536) (clone 93H1, rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 3033S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_331284">AB_331284</ext-link></td><td align="left" valign="bottom">FACS (1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RelB (clone C-19, rabbit polyclonal)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-226; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_632341">AB_632341</ext-link></td><td align="left" valign="bottom">FACS (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-phospho RelB (ser552) (clone D41B9, rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 5025S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10622001">AB_10622001</ext-link></td><td align="left" valign="bottom">FACS (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-DCLK1 (clone D2U3L, rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 62257; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2799622">AB_2799622</ext-link></td><td align="left" valign="bottom">FACS (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K4me3 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab8580; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_306649">AB_306649</ext-link></td><td align="left" valign="bottom">FACS(1:1000)ChIP-seq (2 µg:25 µg chromatin)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-H3K27me3 (clone C36B11, rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9733; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2616029">AB_2616029</ext-link></td><td align="left" valign="bottom">FACS(1:1000)ChIP-seq(1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE-Cy7 anti-CD326 (EpCAM) (clone G8.8, rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat# 25-5791-80; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1724047">AB_1724047</ext-link></td><td align="left" valign="bottom">FACS(1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 anti-Aire (clone 5H12, rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat# 53-5934-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10854132">AB_10854132</ext-link></td><td align="left" valign="bottom">FACS, IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-Ly51 (clone BP-1, mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553735; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_395018">AB_395018</ext-link></td><td align="left" valign="bottom">FACS(1:3000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP-Cy5.5 anti-CD80 (clone 16-10A1, Armenian hamster monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 104722; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2291392">AB_2291392</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">eFluor 450 anti-Ki-67 (clone SolA15, rat monoclonal)</td><td align="left" valign="bottom">eBioscience</td><td align="left" valign="bottom">Cat# 48-5698-82; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11149124">AB_11149124</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Fezf2 (clone F441, rabbit polyclonal)</td><td align="left" valign="bottom">IBL Tecan</td><td align="left" valign="bottom">Cat# JP18997; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2341444">AB_2341444</ext-link></td><td align="left" valign="bottom">FACS, IF(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-Involucrin (clone Poly19244, rabbit polyclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 924401; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2565452">AB_2565452</ext-link></td><td align="left" valign="bottom">IF(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-Ly-6A/E (Sca-1) (clone D7, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553108; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394629">AB_394629</ext-link></td><td align="left" valign="bottom">FACS(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Biotin anti-CD49f (α6-integrin) (clone GoH3, rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 313604; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_345298">AB_345298</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 647 anti-I-Ab (MHCII) (clone AF6-120.1, mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 116412; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493141">AB_493141</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Brilliant Violet 421 anti-CD4 (clone RM4-5, rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 100544; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11219790">AB_11219790</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP-Cy5.5 anti-CD4 (clone RM4-5, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 550954; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_393977">AB_393977</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Pacific Blue anti-CD8α (clone 53-6.7, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 558106; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_397029">AB_397029</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE/Cy7 anti-CD8α (clone 53-6.7, rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 100722; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_312761">AB_312761</ext-link></td><td align="left" valign="bottom">FACS(1:600)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 488 anti-CD44 (clone IM7, rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 103016; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_493679">AB_493679</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-CD69 (clone H1.2F3, rat monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 104508; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_313111">AB_313111</ext-link></td><td align="left" valign="bottom">FACS(1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-CD62L (clone MEL-14, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553151; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394666">AB_394666</ext-link></td><td align="left" valign="bottom">FACS(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PerCP-Cy5.5 anti-CD3ε (clone 17A2, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 560527;RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1727463">AB_1727463</ext-link></td><td align="left" valign="bottom">FACS(1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Alexa Fluor 405 anti-CCL21 (clone 59106, rat monoclonal)</td><td align="left" valign="bottom">R&amp;D Systems</td><td align="left" valign="bottom">Cat# IC457V</td><td align="left" valign="bottom">FACS(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD45 MicroBeads, mouse (clone 30F11.1, rat monoclonal)</td><td align="left" valign="bottom">Miltenyi</td><td align="left" valign="bottom">Cat# 130052301; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2877061">AB_2877061</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cy5 anti-rabbit IgG (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A10523; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534032">AB_2534032</ext-link></td><td align="left" valign="bottom">FACS(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Cyanine 3 anti-rabbit IgG (goat polyclonal)</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# A10520; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534029">AB_2534029</ext-link></td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ2 (clone B20.6, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ3 (clone KJ25, Armenian hamster monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ4 (clone KT4, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ5.1, 5.2 (clone MR9-4, mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553189; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394697">AB_394697</ext-link></td><td align="left" valign="bottom">FACS(1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ6 (clone RR4-7, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-TCR Vβ8.1, 8.2 (clone MR5-2, mouse monoclonal)</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 140103; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10641144">AB_10641144</ext-link></td><td align="left" valign="bottom">FACS(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ9 (clone MR10-2, mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">PE anti-TCR Vβ10b (clone B21.5, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553285; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394757">AB_394757</ext-link></td><td align="left" valign="bottom">FACS(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Biotin anti-TCR Vβ11 (clone RR3-15, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 553196; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_394702">AB_394702</ext-link></td><td align="left" valign="bottom">FACS(1:300)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ12 (clone MR11-1, mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ13 (clone MR12-3, mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ14 (clone 14-2, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">FITC anti-TCR Vβ17a (clone KJ23, rat monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 557004; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_647180">AB_647180</ext-link></td><td align="left" valign="bottom">FACS(20 µl per 10<sup>6</sup> cells)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CD4<sup>+</sup> T cell isolation kit, mouse</td><td align="left" valign="bottom">Miltenyi Biotec</td><td align="left" valign="bottom">Cat# 130-104-454</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">PerCP-Cy5.5 Streptavidin</td><td align="left" valign="bottom">BioLegend</td><td align="left" valign="bottom">Cat# 405214; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2716577">AB_2716577</ext-link></td><td align="left" valign="bottom">FACS(1:400)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Alexa Fluor 488 Streptavidin</td><td align="left" valign="bottom">Invitrogen</td><td align="left" valign="bottom">Cat# S11223</td><td align="left" valign="bottom">IF(1:1000)</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Ovalbumin (323–339)</td><td align="left" valign="bottom">PolyPeptide</td><td align="left" valign="bottom">Cat# SC1303</td><td align="left" valign="bottom">5 μM</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Liberase TM</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 05401127001</td><td align="left" valign="bottom">50 μg/ml</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">DNase I</td><td align="left" valign="bottom">Roche</td><td align="left" valign="bottom">Cat# 10104159001</td><td align="left" valign="bottom">100 μg/ml</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">TRIzol</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 15596018</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom">GraphPad Software</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom">FlowJo</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/">https://www.flowjo.com/</ext-link>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji/ImageJ software</td><td align="left" valign="bottom">Fiji-ImageJ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imagej.nih.gov/ij/">https://imagej.nih.gov/ij/</ext-link>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_003070">SCR_003070</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">7500 Real-Time PCR Software</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com/us/en/home/technical-resources/software-downloads/applied-biosystems-7500-real-time-pcr-system.html">https://www.thermofisher.com/us/en/home/technical-resources/software-downloads/applied-biosystems-7500-real-time-pcr-system.html</ext-link>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014596">SCR_014596</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Pheatmap 0.2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/raivokolde/pheatmap">https://github.com/raivokolde/pheatmap</ext-link> (<xref ref-type="bibr" rid="bib38">Kolde, 2018</xref>)</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016418">SCR_016418</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Seurat</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib26">Hao et al., 2021</xref></td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016341">SCR_016341</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Actin-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGAAGGAGATTACTGCTCTGGCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Actin-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGAGCCACCGATCCACACA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Aire-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCATAGCATCCTGGACGGCTTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Aire-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTGGGCTGGAGACGCTCTTTGAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl19-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTAATGATGCGGAAGACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl19-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTCACATCGACTCTCTAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGGAGCATCCACGTGTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTCATTGGGATCATCTTGCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl22-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTGATGCAGGTCCCTATGGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl22-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGAGTAGCTTCTTCACCCAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl25-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCCTGGTTGCCTGTTTTGTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Ccl25-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACCCAGGCAGCAGTCTTCAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Cdh2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCGCAGTCTTACCGAAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Cdh2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCGCTGCTTTCATACTGAACTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Coch-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GTGCAGCAAAACCTGCTACAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Coch -RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCTAGGACGTTCTCTTTGGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Crabp1-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGCAGCGAGAATTTCGACGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Crabp1-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGCACAGTAGTGGATGTCTTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Crp-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATAGCCATGGAGAAGCTAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Crp-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGTGGCTTCTTTGACTCTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Csn2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTCCACTAAAGGACTTGACAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Csn2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACCTTCTGAAGTTTCTGCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fabp9-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CACTGCAGACAACCGAAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fabp9-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCTGTTTGCCAAGCCATTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fam183b-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGTGTGGGGCAGATGAAGAAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fam183b-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTGAATGAGGTTCAGGAACTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fcer2a-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCAGGAGGATCTAAGGAACGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fcer2a-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCGTCTTGGAGTCTGTTCAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fezf2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGCACTCTCTGCAGACACAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Fezf2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGCCGCACTGGTTACACTTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Grap-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GATCAGGGAGAGTGAGAGTTCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Grap-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAGCTCGTTGAGGGAGTTGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Icam2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATCAACTGCAGCACCAACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Icam2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACTTGAGCTGGAGGCTGGTA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il15-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGCAGATAACCAGCCTACAGGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il15-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGTTGAAGATGAGCTGGCTATGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il21-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGCCTCCTGATTAGACTTCG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il21-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGGAGCTGATAGAAGTTCAGGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il5-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCGCCAAAAAGAGAAGTGTGGCGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il5-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCCTCAGCCTTCCATTGCCCA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il7-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGGTCCTGGGAGTGATTATGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Il7-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGGGAGGTGGGTGTAGTCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Itgad-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGAAAGGGTTCAGACTTTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Itgad-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACACCTCCACGGATAGAAGTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Itgb6-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCTGGTCTGCCTGTTTCTGC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Itgb6-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGAGCAGCTTTCTGCACCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Kcnj5-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAAACCTTAGCGGCTTTGTATCT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Kcnj5-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AAGGCATTAACAATCGAGCCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Krt1-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGGGAGATTTTCAGGAGGAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Krt1-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCCACACTCTTGGAGATGCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Meig1-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CTTCAGCGGAGGGACAATAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Meig1-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CAAGGTTTCAAGGTGGGTGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nov-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">AGACCCCAACAACCAGACTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nov-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CGGTAAATGACCCCATCGAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nts-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GCAAGTCCTCCGTCTTGGAAA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Nts-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGCCAACAAGGTCGTCATCAT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reig1-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGCTAGGAACGCCTACTTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reig1-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCCAAGTTAAACGGTCTTCAGT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Resp18-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CCAGCCAAGATGCAGAGTTCGTTAAAG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Resp18-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCAGTCAGCAACAAGGTTGAGGCCCAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rsph1-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ACGGGGACACATATGAAGGA</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Rsph1-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGCCGTGCTTTTTATTTTTG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Spon2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGAAAACGTGAGTCTTGCC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Spon2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TGATGCTGTATCTAGCCAGAGG</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Sult1c2-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">ATGGCCTTGACCCCAGAAC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Sult1c2-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">TCGAAGGTCTGAATCTGCCTC</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Upk3b-FW</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">CATCTGGCTAGTGGTGGCTTT</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Upk3b-RV</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">PCR primers</td><td align="left" valign="bottom">GGTAATGTCATATAGTGGCCGTC</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">Biotinylated Lotus Tetragonolobus Lectin (LTL)</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat# B-1325; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2336558">AB_2336558</ext-link></td><td align="left" valign="bottom">IF(1:500)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">FITC Ulex Europaeus Agglutinin I (UEA I)</td><td align="left" valign="bottom">Vector Laboratories</td><td align="left" valign="bottom">Cat# FL-1061; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2336767">AB_2336767</ext-link></td><td align="left" valign="bottom">FACS(1:600)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SuperScript II Reverse Transcriptase</td><td align="left" valign="bottom">Thermo Fisher</td><td align="left" valign="bottom">Cat# 18064022</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">SYBR Premix Ex Taq master mix</td><td align="left" valign="bottom">Takara</td><td align="left" valign="bottom">Cat# RR390A</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">miRNeasy Micro Kit</td><td align="left" valign="bottom">QIAGEN</td><td align="left" valign="bottom">Cat# 217084</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">TruSeq ChIP Library Preparation Kit</td><td align="left" valign="bottom">Illumina</td><td align="left" valign="bottom">Cat# IP-202-2012</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>C57BL/6 WT mice were purchased from Charles River. <italic>Ciita<sup>III+IV</sup></italic><sup>-/-</sup> (ΔCD4) (<xref ref-type="bibr" rid="bib42">LeibundGut-Landmann et al., 2004</xref>), MHCII<sup>-/-</sup> (<xref ref-type="bibr" rid="bib48">Madsen et al., 1999</xref>), K14x<italic>Ciita<sup>III</sup></italic> <sup>-/-</sup> (mTEC<sup>ΔMHCII</sup>) (<xref ref-type="bibr" rid="bib29">Irla et al., 2008</xref>), OTII (<xref ref-type="bibr" rid="bib8">Barnden et al., 1998</xref>), RipmOVAxOTII (<xref ref-type="bibr" rid="bib39">Kurts et al., 1996</xref>), and <italic>Rag2</italic><sup>-/-</sup> (<xref ref-type="bibr" rid="bib63">Shinkai et al., 1992</xref>) mice were on C57BL/6J background. OTII and RipmOVAxOTII were backcrossed on <italic>Rag2</italic><sup>-/-</sup> background. All mice were maintained under specific pathogen-free conditions at an ambient temperature of 22°C at the animal facilities of the CIML (Marseille, France). Standard food and water were given ad libitum. Males and females were used at the age of 5–6 weeks. All experiments were done in accordance with national and European laws for laboratory animal welfare (EEC Council Directive 2010/63/UE), and were approved by the Marseille Ethical Committee for Animal Experimentation (Comité National de Réflexion Ethique sur l’Expérimentation Animale no. 14).</p></sec><sec id="s4-2"><title>mTEC purification</title><p>mTECs were isolated by enzymatic digestion with 50 μg/ml of Liberase TM (Roche) and 100 μg/ml of DNase I (Roche) in HBSS medium, as previously described (<xref ref-type="bibr" rid="bib46">Lopes et al., 2017</xref>). CD45<sup>+</sup> hematopoietic cells were depleted using anti-CD45 magnetic beads by autoMACS with the depleteS program (Miltenyi Biotec). Total mTECs (EpCAM<sup>+</sup>UEA-1<sup>+</sup>Ly51<sup>lo</sup>), mTEC<sup>lo</sup> (EpCAM<sup>+</sup>UEA-1<sup>+</sup>Ly51<sup>lo</sup>CD80<sup>lo/int</sup>), and mTEC<sup>hi</sup> (EpCAM<sup>+</sup>UEA-1<sup>+</sup>Ly51<sup>lo</sup>CD80<sup>hi</sup>) were sorted with a FACSAriaIII cell sorter (BD). The purity of sorted mTEC<sup>lo</sup> was &gt;98%. Flow cytometry gating strategies are shown in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>.</p></sec><sec id="s4-3"><title>mTEC antigen presentation assays</title><p>Variable numbers of mTECs from WT and mTEC<sup>ΔMHCII</sup> mice loaded or not with OVA<sub>323-339</sub> (5 µM, PolyPeptide group) were co-cultured with 10<sup>5</sup> OTII CD4<sup>+</sup> T cells (purified with a CD4<sup>+</sup> T cell isolation kit, Miltenyi Biotec) in RPMI medium (Thermo Fisher) supplemented with 10% FCS (Sigma-Aldrich), L-glutamine (2 mM, Thermo Fisher), sodium pyruvate (1 mM, Thermo Fisher), 2-mercaptoethanol (2 × 10<sup>−5</sup> M, Thermo Fisher), penicillin (100 IU/ml, Thermo Fisher), and streptomycin (100 μg/ml, Thermo Fisher). The activation of OTII CD4<sup>+</sup> T cells was assessed 18 hr later by flow cytometry based on the upregulation of the CD69 marker.</p></sec><sec id="s4-4"><title>Flow cytometry</title><p>TECs, thymocytes, and splenic T cells were analyzed by flow cytometry (FACSCanto II, BD) with standard procedures. Cells were incubated for 15 min at 4°C with Fc-block (anti-CD16/CD32, 2.4G2, BD Biosciences) before staining. Antibodies are listed in the Key resources table. For intracellular staining with anti-Foxp3, anti-Ki-67, anti-p38 MAPK, anti-phospho p38 MAPK (Thr180/Tyr182), anti-IKKα, anti-phospho IKKα(Ser180)/IKKβ(Ser181), anti-Erk1/2 MAPK, anti-phospho Erk1/2 MAPK (Thr202/Tyr204), anti-p65, anti-phospho p65(ser536), anti-RelB, anti-phospho RelB(ser552), and anti-DCLK1 antibodies, cells were fixed, permeabilized, and stained with the Foxp3 staining kit according to the manufacturer’s instructions (eBioscience). Intracellular staining with anti-Aire, anti-Fezf2, anti-CCL21, anti-H3K4me3, and anti-H3K27me3 antibodies was performed with Fixation/Permeabilization Solution Kit (BD). Secondary antibodies (II Abs) were used to set positive staining gates. Flow cytometry analysis was performed with a FACSCanto II (BD), and data were analyzed using FlowJo software (BD).</p></sec><sec id="s4-5"><title>Quantitative RT-PCR</title><p>Total RNA was prepared with TRIzol (Invitrogen). cDNAs was synthesized with oligo(dT) using Superscript II reverse transcriptase (Invitrogen). qPCR was performed with the ABI 7500 fast real-time PCR system (Applied Biosystems) and SYBR Premix Ex Taq master mix (Takara). Primers are listed in the Key resources table.</p></sec><sec id="s4-6"><title>In vivo transfer of splenocytes into <italic>Rag2</italic><sup>-/-</sup> recipients</title><p>3.10<sup>6</sup> splenocytes purified from the spleen of WT and mTEC<sup>ΔMHCII</sup> mice of 8 weeks of age were intravenously injected into <italic>Rag2<sup>-/-</sup></italic> female recipients. CD3<sup>+</sup>, CD4<sup>+</sup>, and CD8<sup>+</sup> T-cell infiltrates were analyzed 6 weeks after transfer by histology and flow cytometry in different peripheral tissues.</p></sec><sec id="s4-7"><title>Histology</title><p>Tissues were fixed in 10% buffered formalin (Sigma) and embedded in paraffin blocks. 4-μm-thick sections were stained with hematoxylin-eosin (Thermo Fisher) and analyzed by light microscopy (Nikon Statif eclipse Ci-L). For immunofluorescence experiments, frozen thymic sections were stained as previously described (<xref ref-type="bibr" rid="bib60">Sergé et al., 2015</xref>) with Alexa Fluor 488 or Alexa Fluor 647-conjugated anti-Aire (5H12; eBioscience), biotinylated anti-TPA (LTL; Vector Laboratories), rabbit anti-Fezf2 (F441; IBL Tecan), and rabbit anti-involucrin (BioLegend) antibodies. Rabbit anti-Fezf2 and rabbit anti-involucrin were revealed with Cy3-conjugated anti-rabbit IgG (Invitrogen), and biotinylated anti-TPA was revealed with Alexa Fluor 488-conjugated streptavidin (Invitrogen). Sections were mounted with Mowiol (Calbiochem). Immunofluorescence confocal microscopy was performed with a LSM780 Leica SP5X confocal microscope. Images were analyzed with ImageJ software.</p></sec><sec id="s4-8"><title>RNA-seq experiments</title><p>Total RNA purified from mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) was extracted with miRNeasy Micro Kit (QIAGEN), and RNA quality was assessed on an Agilent 2100 BioAnalyzer (Agilent Technologies). RNA Integrity Number values over 8 were obtained. RNA-seq libraries were generated using the SMART-Seq-v4-Ultra Low Input RNA Kit (Clontech) combined to the Nextera library preparation kit (Illumina) following the manufacturer’s instructions. Libraries were sequenced with the Illumina NextSeq 500 machine to generate datasets of single-end 75 bp reads. Two independent biological replicates were used per each condition. RNA-seq data have been deposited with Gene Expression Omnibus (GEO) under the accession number GSE144650.</p></sec><sec id="s4-9"><title>RNA-seq analysis</title><p>The sequencing reads were mapped to the <italic>Mus musculus</italic> (mm10) reference genome using the TopHat 2 (version 2.0.12) aligner (<xref ref-type="bibr" rid="bib34">Kim et al., 2013</xref>). The reads mapping to the annotated genes (igenome UCSC mm10 GTF: <ext-link ext-link-type="uri" xlink:href="https://support.illumina.com/sequencing/sequencing_software/igenome.html">https://support.illumina.com/sequencing/sequencing_software/igenome.html</ext-link>) were counted, normalized, and compared using Cuffdiff2 (version 2.2.1; <xref ref-type="bibr" rid="bib65">Trapnell et al., 2013</xref>) between two conditions. Cuffdiff2 generated expression levels as FPKM, FCs, and p-values to assess the statistical significance of the FPKM difference of each gene between the tested two conditions. Genes showing a significant variation in gene expression between WT and ΔCD4, or WT and mTEC<sup>ΔMHCII</sup>, or RIPmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> and OTII-<italic>Rag2</italic><sup>-/-</sup> mice (p-value≤0.05, FC difference ≥ 2 or ≤ 0.5) were considered as up- or downregulated. The TRA and non-TRA gene assignments were obtained from <xref ref-type="bibr" rid="bib59">Sansom et al., 2014</xref>. In this report, the identification of the specificity of expression for each gene in the genome was carried out by analyzing the microarray expression profiles of a large number of different mouse tissues. Aire-dependent, Fezf2-dependent, Aire/Fezf2-dependent, and Aire/Fezf2-independent TRAs were identified using <italic>Aire</italic><sup>-/-</sup> mTEC<sup>hi</sup> RNA-seq datasets and <italic>Fezf2</italic><sup>-/-</sup> total mTEC microarray datasets, obtained from the NCBI GEO database (GSE87133 and GSE69105, respectively).</p><p>Correlation between the variation of gene expression in mTEC<sup>lo</sup> from WT versus mTEC<sup>ΔMHCII</sup> or RIPmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> versus OTII-<italic>Rag2</italic><sup>-/-</sup> mice, and of the same genes in mTEC<sup>hi</sup> from WT versus <italic>Aire<sup>-</sup></italic><sup>/-</sup> mice was performed doing a locally regression (loess) with the R software (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>). Differential gene expression in WT versus <italic>Aire</italic><sup>-/-</sup> mTEC<sup>hi</sup> was obtained by processing using TopHat2 and Cuffdiff2, the sequencing reads corresponding to WT (<xref ref-type="bibr" rid="bib13">Chuprin et al., 2015</xref>) and <italic>Aire</italic><sup>-/-</sup> (<xref ref-type="bibr" rid="bib15">Danan-Gotthold et al., 2016</xref>) mTEC<sup>hi</sup> RNA-seq datasets, which were obtained from the NCBI GEO database (GSE68190 and GSE87133, respectively). HDAC3-dependent mTEC-specific transcription factors regulated by mTEC-thymocyte crosstalk were identified by comparing the top 50 transcriptional regulators that are induced by HDAC3 (<xref ref-type="bibr" rid="bib21">Goldfarb et al., 2016</xref>) with genes upregulated in the different mouse models. TRAs differentially expressed between mTEC<sup>lo</sup> from WT and mTEC<sup>ΔMHCII</sup> mice were classified according to their tissue distribution using the mouse ENCODE transcriptome database (<xref ref-type="bibr" rid="bib75">Yue, 2014</xref>). Only tissues that showed the highest expression were taken into account.</p></sec><sec id="s4-10"><title>Single-cell RNA-seq analysis</title><p>Single-cell RNA-seq count matrix from <xref ref-type="bibr" rid="bib71">Wells et al., 2020</xref> (accession number GSE137699) was reanalyzed with the Seurat package (<xref ref-type="bibr" rid="bib26">Hao et al., 2021</xref>). QC analysis was performed by filtering out cells with a number of feature counts under 200 or over 4000, and a proportion of mitochondrial counts over 4%. Sample integration was performed as described in the Seurat vignette. After PCA for dimension reduction, 15 first dimensions were conserved. Cells were clustered and visualized with UMAP. Cluster annotation was performed by identifying sets of specific markers to each cluster using a differential expression test (FindMarkers function, test = ‘roc’). Heatmaps were generated using the pheatmap R package.</p></sec><sec id="s4-11"><title>Nano-ChIP-seq experiments</title><p>Nano-ChIP-seq was performed as previously described (<xref ref-type="bibr" rid="bib1">Adli and Bernstein, 2011</xref>) on 5.10<sup>4</sup> purified mTEC<sup>lo</sup> (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). ChIP-seq libraries were prepared with TruSeq ChIP Sample Preparation Kit (Illumina), and 2 × 75 bp paired-end reads were sequenced on an Illumina HiSeq. ChIP-seq data have been deposited with GEO under the accession number GSE144680.</p></sec><sec id="s4-12"><title>ChIP-seq analysis</title><p>Reads were aligned on the mouse genome (mm10) using Bowtie 2 and default parameters (<xref ref-type="bibr" rid="bib41">Langmead and Salzberg, 2012</xref>). Properly paired alignments were selected using Samtools view with the 0x2flag (-f option). Nonuniquely mapped reads-pairs were filtered out by removing reads with the ‘XS’ tag set by Bowtie 2. Normalized bedgraphs for ChIP and input samples were generated using MACS2 (<xref ref-type="bibr" rid="bib77">Zhang et al., 2008</xref>) with the callpeak command in BAMPE mode with the --SPMR option. For the diffused H3K27me3 histone mark, the -broad option was used. ChIP enrichment was calculated parsing the ChIP and input normalized bedgraphs with MACS2 and the bdgcmp command (-m FE option). The obtained bedgraphs were converted to wig using the bedGraphToWig.pl script with the --step 10 parameter. MACS2-generated peak calling files were converted to BED files using the cut -f 1-6 command. The obtained Wig and BED files were parsed by CEAS (<xref ref-type="bibr" rid="bib62">Shin et al., 2009</xref>) to generate metagene profile plots corresponding to the average enrichment of H3K4me3 in 3 kb TSS windows or H3K27me3 at gene loci. H3K4me3 and H3K27me3 CEAS-dumped files were parsed to compute ratios of ChIP/input in 1 kb TSS windows and gene loci, respectively. Statistical significance between ChIP enrichment data was tested using the nonparametric Mann–Whitney test. Data were visualized using the Integrative Genomics Viewer (IGV) (<xref ref-type="bibr" rid="bib57">Robinson et al., 2011</xref>).</p></sec><sec id="s4-13"><title>Statistics</title><p>Data are presented as means ± standard error of mean (SEM). Statistical analysis was performed with GraphPad Prism 7.03 software by using ANOVA, chi-square, unpaired Student’s <italic>t</italic>-test, or Mann–Whitney test. ****p&lt;0.0001, ***p&lt;0.001, **p&lt;0.01, *p&lt;0.05. Normal distribution of the data was assessed using d’Agostino–Pearson omnibus normality test.</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Formal analysis, Investigation, Methodology, Validation, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Methodology, Validation</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Validation</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Data curation, Formal analysis, Visualization</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Methodology, Software, Validation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Methodology, Software, Validation, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Visualization, Writing – original draft, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All mice were housed, bred and manipulated under specific pathogen-free conditions at the animal facilities of the CIML (Marseille, France). All experiments were done in accordance with national and European laws for laboratory animal welfare (EEC Council Directive 2010/63/UE), and were approved by the Marseille Ethical Committee for Animal Experimentation (Comité National de Réflexion Ethique sur l'Expérimentation Animale no. 14; Permit Number: 02373.03).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of tissue-restricted self-antigens (TRAs) differentially expressed in mTEC<sup>lo</sup> from WT and ΔCD4 mice.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69982-supp1-v2.pdf"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>List of tissue-restricted self-antigens (TRAs) differentially expressed in mTEC<sup>lo</sup> from WT and mTEC<sup>ΔMHCII</sup> mice.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69982-supp2-v2.pdf"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>List of tissue-restricted self-antigens (TRAs) differentially expressed in mTEC<sup>lo</sup> from OTII-<italic>Rag2</italic><sup>-/-</sup> and RipmOVAxOTII-<italic>Rag2</italic><sup>-/-</sup> mice.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69982-supp3-v2.pdf"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Main target organs and fold change associated with the expression of tissue-restricted self-antigens (TRAs) differentially expressed in mTEC<sup>lo</sup> from WT and mTEC<sup>ΔMHCII</sup> mice.</title></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69982-supp4-v2.pdf"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-69982-transrepform1-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>RNA-seq data have been deposited in GEO under the accession number GSE144650. ChIP-seq data have been deposited in GEO under the accession number GSE144680.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>mTEClo/int RNAseq profiling in three mouse models of impaired mTEC/Tcell crosstalk</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144650">GSE144650</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name><collab>Giraud M</collab></person-group><year iso-8601-date="2020">2020</year><data-title>Chromatin state of mTEClo/int in the RipmOVAxOTII mTEC/Tcell crosstalk mouse model</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE144680">GSE144680</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>ingle cell sequencing defines a branched progenitor population of stable medullary thymic epithelial cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE137699">GSE137699</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Aire-KO MEChi RNAseq profiling</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE87133">GSE87133</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Sirt1 is essential for Aire-mediated induction of central immunological tolerance</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68190">GSE68190</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Pr. Arnauld Sergé (LAI, Marseille, France) for critical reading of the manuscript, Pr. Walter Reith (University of Geneva, Switzerland) for providing <italic>Ciita<sup>III+IV</sup></italic><sup>-/-</sup> and K14x<italic>Ciita<sup>III</sup></italic> <sup>-/-</sup> mice, and Dr. Bruno Lucas (Institut Cochin, Paris, France) for providing MHCII<sup>-/-</sup> mice. We also thank Cloé Zamit and Alexia Borelli (CIML, Marseille, France) for help with mouse genotyping and Lionel Chasson (CIML, Marseille, France) for help with paraffin-embedded tissues. We acknowledge the flow cytometry, the imaging core (ImagImm) and animal facility platforms at CIML for excellent technical support. NL and JC were supported by a PhD fellowship from Aix-Marseille University and the Ministère de l’Enseignement Supérieur et de la Recherche, respectively.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adli</surname><given-names>M</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq</article-title><source>Nature Protocols</source><volume>6</volume><fpage>1656</fpage><lpage>1668</lpage><pub-id pub-id-type="doi">10.1038/nprot.2011.402</pub-id><pub-id pub-id-type="pmid">21959244</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Shimo</surname><given-names>Y</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>D</given-names></name><name><surname>Maruyama</surname><given-names>Y</given-names></name><name><surname>Asaumi</surname><given-names>Y</given-names></name><name><surname>Kitazawa</surname><given-names>J</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>J-I</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance</article-title><source>Immunity</source><volume>29</volume><fpage>423</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.06.015</pub-id><pub-id pub-id-type="pmid">18799149</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akiyama</surname><given-names>N</given-names></name><name><surname>Shinzawa</surname><given-names>M</given-names></name><name><surname>Miyauchi</surname><given-names>M</given-names></name><name><surname>Yanai</surname><given-names>H</given-names></name><name><surname>Tateishi</surname><given-names>R</given-names></name><name><surname>Shimo</surname><given-names>Y</given-names></name><name><surname>Ohshima</surname><given-names>D</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>I</given-names></name><name><surname>Hoshino</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Yagi</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>J</given-names></name><name><surname>Kaisho</surname><given-names>T</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Limitation of immune tolerance-inducing thymic epithelial cell development by Spi-B-mediated negative feedback regulation</article-title><source>The Journal of Experimental Medicine</source><volume>211</volume><fpage>2425</fpage><lpage>2438</lpage><pub-id pub-id-type="doi">10.1084/jem.20141207</pub-id><pub-id pub-id-type="pmid">25385757</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>MS</given-names></name><name><surname>Venanzi</surname><given-names>ES</given-names></name><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Berzins</surname><given-names>SP</given-names></name><name><surname>Turley</surname><given-names>SJ</given-names></name><name><surname>von Boehmer</surname><given-names>H</given-names></name><name><surname>Bronson</surname><given-names>R</given-names></name><name><surname>Dierich</surname><given-names>A</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Projection of an immunological self shadow within the thymus by the aire protein</article-title><source>Science</source><volume>298</volume><fpage>1395</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1126/science.1075958</pub-id><pub-id pub-id-type="pmid">12376594</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asano</surname><given-names>T</given-names></name><name><surname>Okamoto</surname><given-names>K</given-names></name><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Tsutsumi</surname><given-names>M</given-names></name><name><surname>Muro</surname><given-names>R</given-names></name><name><surname>Suematsu</surname><given-names>A</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Okamura</surname><given-names>T</given-names></name><name><surname>Ehata</surname><given-names>S</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Soluble RANKL is physiologically dispensable but accelerates tumour metastasis to bone</article-title><source>Nature Metabolism</source><volume>1</volume><fpage>868</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1038/s42255-019-0104-1</pub-id><pub-id pub-id-type="pmid">32694743</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Nakamoto</surname><given-names>Y</given-names></name><name><surname>Mukaida</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Crucial contribution of thymic Sirp alpha+ conventional dendritic cells to central tolerance against blood-borne antigens in a CCR2-dependent manner</article-title><source>Journal of Immunology</source><volume>183</volume><fpage>3053</fpage><lpage>3063</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900438</pub-id><pub-id pub-id-type="pmid">19675159</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baran-Gale</surname><given-names>J</given-names></name><name><surname>Morgan</surname><given-names>MD</given-names></name><name><surname>Maio</surname><given-names>S</given-names></name><name><surname>Dhalla</surname><given-names>F</given-names></name><name><surname>Calvo-Asensio</surname><given-names>I</given-names></name><name><surname>Deadman</surname><given-names>ME</given-names></name><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Maynard</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>F</given-names></name><name><surname>Sit</surname><given-names>RV</given-names></name><name><surname>Neff</surname><given-names>NF</given-names></name><name><surname>Darmanis</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>May</surname><given-names>AP</given-names></name><name><surname>Marioni</surname><given-names>JC</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ageing compromises mouse thymus function and remodels epithelial cell differentiation</article-title><source>eLife</source><volume>9</volume><elocation-id>e56221</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.56221</pub-id><pub-id pub-id-type="pmid">32840480</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnden</surname><given-names>MJ</given-names></name><name><surname>Allison</surname><given-names>J</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements</article-title><source>Immunology and Cell Biology</source><volume>76</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1046/j.1440-1711.1998.00709.x</pub-id><pub-id pub-id-type="pmid">9553774</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borelli</surname><given-names>A</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Lymphotoxin: from the physiology to the regeneration of the thymic function</article-title><source>Cell Death and Differentiation</source><volume>28</volume><fpage>2305</fpage><lpage>2314</lpage><pub-id pub-id-type="doi">10.1038/s41418-021-00834-8</pub-id><pub-id pub-id-type="pmid">34290396</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bornstein</surname><given-names>C</given-names></name><name><surname>Nevo</surname><given-names>S</given-names></name><name><surname>Giladi</surname><given-names>A</given-names></name><name><surname>Kadouri</surname><given-names>N</given-names></name><name><surname>Pouzolles</surname><given-names>M</given-names></name><name><surname>Gerbe</surname><given-names>F</given-names></name><name><surname>David</surname><given-names>E</given-names></name><name><surname>Machado</surname><given-names>A</given-names></name><name><surname>Chuprin</surname><given-names>A</given-names></name><name><surname>Tóth</surname><given-names>B</given-names></name><name><surname>Goldberg</surname><given-names>O</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>N</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name><name><surname>Zimmermann</surname><given-names>VS</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Amit</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Single-cell mapping of the thymic stroma identifies IL-25-producing tuft epithelial cells</article-title><source>Nature</source><volume>559</volume><fpage>622</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0346-1</pub-id><pub-id pub-id-type="pmid">30022162</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkly</surname><given-names>L</given-names></name><name><surname>Hession</surname><given-names>C</given-names></name><name><surname>Ogata</surname><given-names>L</given-names></name><name><surname>Reilly</surname><given-names>C</given-names></name><name><surname>Marconi</surname><given-names>LA</given-names></name><name><surname>Olson</surname><given-names>D</given-names></name><name><surname>Tizard</surname><given-names>R</given-names></name><name><surname>Cate</surname><given-names>R</given-names></name><name><surname>Lo</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Expression of relB is required for the development of thymic medulla and dendritic cells</article-title><source>Nature</source><volume>373</volume><fpage>531</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1038/373531a0</pub-id><pub-id pub-id-type="pmid">7845467</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cédile</surname><given-names>O</given-names></name><name><surname>Løbner</surname><given-names>M</given-names></name><name><surname>Toft-Hansen</surname><given-names>H</given-names></name><name><surname>Frank</surname><given-names>I</given-names></name><name><surname>Wlodarczyk</surname><given-names>A</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name><name><surname>Owens</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Thymic CCL2 influences induction of T-cell tolerance</article-title><source>Journal of Autoimmunity</source><volume>55</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2014.07.004</pub-id><pub-id pub-id-type="pmid">25129504</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuprin</surname><given-names>A</given-names></name><name><surname>Avin</surname><given-names>A</given-names></name><name><surname>Goldfarb</surname><given-names>Y</given-names></name><name><surname>Herzig</surname><given-names>Y</given-names></name><name><surname>Levi</surname><given-names>B</given-names></name><name><surname>Jacob</surname><given-names>A</given-names></name><name><surname>Sela</surname><given-names>A</given-names></name><name><surname>Katz</surname><given-names>S</given-names></name><name><surname>Grossman</surname><given-names>M</given-names></name><name><surname>Guyon</surname><given-names>C</given-names></name><name><surname>Rathaus</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>HY</given-names></name><name><surname>Sagi</surname><given-names>I</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name><name><surname>McBurney</surname><given-names>MW</given-names></name><name><surname>Husebye</surname><given-names>ES</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The deacetylase Sirt1 is an essential regulator of Aire-mediated induction of central immunological tolerance</article-title><source>Nature Immunology</source><volume>16</volume><fpage>737</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1038/ni.3194</pub-id><pub-id pub-id-type="pmid">26006015</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>JE</given-names></name><name><surname>Baik</surname><given-names>S</given-names></name><name><surname>McCarthy</surname><given-names>NI</given-names></name><name><surname>Parnell</surname><given-names>SM</given-names></name><name><surname>White</surname><given-names>AJ</given-names></name><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Aire controls the recirculation of murine Foxp3<sup>+</sup> regulatory T-cells back to the thymus</article-title><source>European Journal of Immunology</source><volume>48</volume><fpage>844</fpage><lpage>854</lpage><pub-id pub-id-type="doi">10.1002/eji.201747375</pub-id><pub-id pub-id-type="pmid">29285761</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danan-Gotthold</surname><given-names>M</given-names></name><name><surname>Guyon</surname><given-names>C</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name><name><surname>Levanon</surname><given-names>EY</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Extensive RNA editing and splicing increase immune self-representation diversity in medullary thymic epithelial cells</article-title><source>Genome Biology</source><volume>17</volume><elocation-id>219</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-016-1079-9</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derbinski</surname><given-names>J.</given-names></name><name><surname>Schulte</surname><given-names>A</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Klein</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self</article-title><source>Nature Immunology</source><volume>2</volume><fpage>1032</fpage><lpage>1039</lpage><pub-id pub-id-type="doi">10.1038/ni723</pub-id><pub-id pub-id-type="pmid">11600886</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derbinski</surname><given-names>Jens</given-names></name><name><surname>Gäbler</surname><given-names>J</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Tierling</surname><given-names>S</given-names></name><name><surname>Jonnakuty</surname><given-names>S</given-names></name><name><surname>Hergenhahn</surname><given-names>M</given-names></name><name><surname>Peltonen</surname><given-names>L</given-names></name><name><surname>Walter</surname><given-names>J</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels</article-title><source>The Journal of Experimental Medicine</source><volume>202</volume><fpage>33</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1084/jem.20050471</pub-id><pub-id pub-id-type="pmid">15983066</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhalla</surname><given-names>F</given-names></name><name><surname>Baran-Gale</surname><given-names>J</given-names></name><name><surname>Maio</surname><given-names>S</given-names></name><name><surname>Chappell</surname><given-names>L</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Biologically indeterminate yet ordered promiscuous gene expression in single medullary thymic epithelial cells</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e101828</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019101828</pub-id><pub-id pub-id-type="pmid">31657037</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gäbler</surname><given-names>J</given-names></name><name><surname>Arnold</surname><given-names>J</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Promiscuous gene expression and the developmental dynamics of medullary thymic epithelial cells</article-title><source>European Journal of Immunology</source><volume>37</volume><fpage>3363</fpage><lpage>3372</lpage><pub-id pub-id-type="doi">10.1002/eji.200737131</pub-id><pub-id pub-id-type="pmid">18000951</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giraud</surname><given-names>M</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Rahl</surname><given-names>PB</given-names></name><name><surname>Young</surname><given-names>RA</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Aire unleashes stalled RNA polymerase to induce ectopic gene expression in thymic epithelial cells</article-title><source>PNAS</source><volume>109</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1073/pnas.1119351109</pub-id><pub-id pub-id-type="pmid">22203960</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldfarb</surname><given-names>Y</given-names></name><name><surname>Kadouri</surname><given-names>N</given-names></name><name><surname>Levi</surname><given-names>B</given-names></name><name><surname>Sela</surname><given-names>A</given-names></name><name><surname>Herzig</surname><given-names>Y</given-names></name><name><surname>Cohen</surname><given-names>RN</given-names></name><name><surname>Hollenberg</surname><given-names>AN</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HDAC3 Is a Master Regulator of mTEC Development</article-title><source>Cell Reports</source><volume>15</volume><fpage>651</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.03.048</pub-id><pub-id pub-id-type="pmid">27068467</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>DHD</given-names></name><name><surname>Seach</surname><given-names>N</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Milton</surname><given-names>MK</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Lew</surname><given-names>AM</given-names></name><name><surname>Goodnow</surname><given-names>CC</given-names></name><name><surname>Boyd</surname><given-names>RL</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Developmental kinetics, turnover, and stimulatory capacity of thymic epithelial cells</article-title><source>Blood</source><volume>108</volume><fpage>3777</fpage><lpage>3785</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-02-004531</pub-id><pub-id pub-id-type="pmid">16896157</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>D</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Proliferative arrest and rapid turnover of thymic epithelial cells expressing Aire</article-title><source>The Journal of Experimental Medicine</source><volume>204</volume><fpage>2521</fpage><lpage>2528</lpage><pub-id pub-id-type="doi">10.1084/jem.20070795</pub-id><pub-id pub-id-type="pmid">17908938</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haljasorg</surname><given-names>U</given-names></name><name><surname>Dooley</surname><given-names>J</given-names></name><name><surname>Laan</surname><given-names>M</given-names></name><name><surname>Kisand</surname><given-names>K</given-names></name><name><surname>Bichele</surname><given-names>R</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Peterson</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Irf4 Expression in Thymic Epithelium Is Critical for Thymic Regulatory T Cell Homeostasis</article-title><source>Journal of Immunology</source><volume>198</volume><fpage>1952</fpage><lpage>1960</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1601698</pub-id><pub-id pub-id-type="pmid">28108558</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Handel</surname><given-names>AE</given-names></name><name><surname>Shikama-Dorn</surname><given-names>N</given-names></name><name><surname>Zhanybekova</surname><given-names>S</given-names></name><name><surname>Maio</surname><given-names>S</given-names></name><name><surname>Graedel</surname><given-names>AN</given-names></name><name><surname>Zuklys</surname><given-names>S</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Comprehensively Profiling the Chromatin Architecture of Tissue Restricted Antigen Expression in Thymic Epithelial Cells Over Development</article-title><source>Frontiers in Immunology</source><volume>9</volume><elocation-id>2120</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2018.02120</pub-id><pub-id pub-id-type="pmid">30283453</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>S</given-names></name><name><surname>Andersen-Nissen</surname><given-names>E</given-names></name><name><surname>Mauck</surname><given-names>WM</given-names></name><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Wilk</surname><given-names>AJ</given-names></name><name><surname>Darby</surname><given-names>C</given-names></name><name><surname>Zager</surname><given-names>M</given-names></name><name><surname>Hoffman</surname><given-names>P</given-names></name><name><surname>Stoeckius</surname><given-names>M</given-names></name><name><surname>Papalexi</surname><given-names>E</given-names></name><name><surname>Mimitou</surname><given-names>EP</given-names></name><name><surname>Jain</surname><given-names>J</given-names></name><name><surname>Srivastava</surname><given-names>A</given-names></name><name><surname>Stuart</surname><given-names>T</given-names></name><name><surname>Fleming</surname><given-names>LM</given-names></name><name><surname>Yeung</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>AJ</given-names></name><name><surname>McElrath</surname><given-names>JM</given-names></name><name><surname>Blish</surname><given-names>CA</given-names></name><name><surname>Gottardo</surname><given-names>R</given-names></name><name><surname>Smibert</surname><given-names>P</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated analysis of multimodal single-cell data</article-title><source>Cell</source><volume>184</volume><fpage>3573</fpage><lpage>3587</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.04.048</pub-id><pub-id pub-id-type="pmid">34062119</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hikosaka</surname><given-names>Y</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Ohigashi</surname><given-names>I</given-names></name><name><surname>Yano</surname><given-names>K</given-names></name><name><surname>Ishimaru</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>K</given-names></name><name><surname>Penninger</surname><given-names>JM</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name><name><surname>Yokota</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Yoshikai</surname><given-names>Y</given-names></name><name><surname>Inoue</surname><given-names>J-I</given-names></name><name><surname>Akiyama</surname><given-names>T</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator</article-title><source>Immunity</source><volume>29</volume><fpage>438</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.06.018</pub-id><pub-id pub-id-type="pmid">18799150</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Lancaster</surname><given-names>JN</given-names></name><name><surname>Sasiponganan</surname><given-names>C</given-names></name><name><surname>Ehrlich</surname><given-names>LIR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CCR4 promotes medullary entry and thymocyte-dendritic cell interactions required for central tolerance</article-title><source>The Journal of Experimental Medicine</source><volume>212</volume><fpage>1947</fpage><lpage>1965</lpage><pub-id pub-id-type="doi">10.1084/jem.20150178</pub-id><pub-id pub-id-type="pmid">26417005</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name><name><surname>Hugues</surname><given-names>S</given-names></name><name><surname>Gill</surname><given-names>J</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Hikosaka</surname><given-names>Y</given-names></name><name><surname>Williams</surname><given-names>IR</given-names></name><name><surname>Hubert</surname><given-names>FX</given-names></name><name><surname>Scott</surname><given-names>HS</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Autoantigen-specific interactions with CD4+ thymocytes control mature medullary thymic epithelial cell cellularity</article-title><source>Immunity</source><volume>29</volume><fpage>451</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.08.007</pub-id><pub-id pub-id-type="pmid">18799151</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name><name><surname>Hollander</surname><given-names>G</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of central self-tolerance induction by autoreactive CD4+ thymocytes</article-title><source>Trends in Immunology</source><volume>31</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.it.2009.11.002</pub-id><pub-id pub-id-type="pmid">20004147</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name><name><surname>Guerri</surname><given-names>L</given-names></name><name><surname>Guenot</surname><given-names>J</given-names></name><name><surname>Sergé</surname><given-names>A</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name><name><surname>Liston</surname><given-names>A</given-names></name><name><surname>Imhof</surname><given-names>BA</given-names></name><name><surname>Palmer</surname><given-names>E</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Antigen recognition by autoreactive CD4+ thymocytes drives homeostasis of the thymic medulla</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e52591</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0052591</pub-id><pub-id pub-id-type="pmid">23300712</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RANK Signaling in the Differentiation and Regeneration of Thymic Epithelial Cells</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>623265</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.623265</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kadouri</surname><given-names>N</given-names></name><name><surname>Nevo</surname><given-names>S</given-names></name><name><surname>Goldfarb</surname><given-names>Y</given-names></name><name><surname>Abramson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Thymic epithelial cell heterogeneity: TEC by TEC</article-title><source>Nature Reviews. Immunology</source><volume>20</volume><fpage>239</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0238-0</pub-id><pub-id pub-id-type="pmid">31804611</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Pertea</surname><given-names>G</given-names></name><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Pimentel</surname><given-names>H</given-names></name><name><surname>Kelley</surname><given-names>R</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biology</source><volume>14</volume><elocation-id>R36</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id><pub-id pub-id-type="pmid">23618408</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Allen</surname><given-names>PM</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see)</article-title><source>Nature Reviews. Immunology</source><volume>14</volume><fpage>377</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1038/nri3667</pub-id><pub-id pub-id-type="pmid">24830344</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>L</given-names></name><name><surname>Robey</surname><given-names>EA</given-names></name><name><surname>Hsieh</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Central CD4<sup>+</sup> T cell tolerance: deletion versus regulatory T cell differentiation</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0083-6</pub-id><pub-id pub-id-type="pmid">30420705</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname><given-names>AS</given-names></name><name><surname>Miller</surname><given-names>EL</given-names></name><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Moskowitz</surname><given-names>DM</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Crabtree</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rapid chromatin repression by Aire provides precise control of immune tolerance</article-title><source>Nature Immunology</source><volume>19</volume><fpage>162</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1038/s41590-017-0032-8</pub-id><pub-id pub-id-type="pmid">29335648</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Kolde</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>pheatmap</data-title><version designator="b333453">b333453</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/raivokolde/pheatmap">https://github.com/raivokolde/pheatmap</ext-link></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurts</surname><given-names>C</given-names></name><name><surname>Heath</surname><given-names>WR</given-names></name><name><surname>Carbone</surname><given-names>FR</given-names></name><name><surname>Allison</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>JF</given-names></name><name><surname>Kosaka</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Constitutive class I-restricted exogenous presentation of self antigens in vivo</article-title><source>The Journal of Experimental Medicine</source><volume>184</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1084/jem.184.3.923</pub-id><pub-id pub-id-type="pmid">9064352</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Klein</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A central role for central tolerance</article-title><source>Annual Review of Immunology</source><volume>24</volume><fpage>571</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.23.021704.115601</pub-id><pub-id pub-id-type="pmid">16551260</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Fast gapped-read alignment with Bowtie 2</article-title><source>Nature Methods</source><volume>9</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id><pub-id pub-id-type="pmid">22388286</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeibundGut-Landmann</surname><given-names>S</given-names></name><name><surname>Waldburger</surname><given-names>J-M</given-names></name><name><surname>Reis e Sousa</surname><given-names>C</given-names></name><name><surname>Acha-Orbea</surname><given-names>H</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells</article-title><source>Nature Immunology</source><volume>5</volume><fpage>899</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1038/ni1109</pub-id><pub-id pub-id-type="pmid">15322541</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lkhagvasuren</surname><given-names>E</given-names></name><name><surname>Sakata</surname><given-names>M</given-names></name><name><surname>Ohigashi</surname><given-names>I</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lymphotoxin β receptor regulates the development of CCL21-expressing subset of postnatal medullary thymic epithelial cells</article-title><source>Journal of Immunology</source><volume>190</volume><fpage>5110</fpage><lpage>5117</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203203</pub-id><pub-id pub-id-type="pmid">23585674</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomada</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Coghlan</surname><given-names>L</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Richie</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Thymus medulla formation and central tolerance are restored in IKKalpha-/- mice that express an IKKalpha transgene in keratin 5+ thymic epithelial cells</article-title><source>Journal of Immunology</source><volume>178</volume><fpage>829</fpage><lpage>837</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.2.829</pub-id><pub-id pub-id-type="pmid">17202344</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Serge</surname><given-names>A</given-names></name><name><surname>Ferrier</surname><given-names>P</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Thymic Crosstalk Coordinates Medulla Organization and T-Cell Tolerance Induction</article-title><source>Frontiers in Immunology</source><volume>6</volume><elocation-id>365</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00365</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Vachon</surname><given-names>H</given-names></name><name><surname>Marie</surname><given-names>J</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Administration of RANKL boosts thymic regeneration upon bone marrow transplantation</article-title><source>EMBO Molecular Medicine</source><volume>9</volume><fpage>835</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.15252/emmm.201607176</pub-id><pub-id pub-id-type="pmid">28455312</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>N</given-names></name><name><surname>Charaix</surname><given-names>J</given-names></name><name><surname>Cedile</surname><given-names>O</given-names></name><name><surname>Serge</surname><given-names>A</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Lymphotoxin alpha fine-tunes T cell clonal deletion by regulating thymic entry of antigen-presenting cells</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>1262</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-03619-9</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madsen</surname><given-names>L</given-names></name><name><surname>Labrecque</surname><given-names>N</given-names></name><name><surname>Engberg</surname><given-names>J</given-names></name><name><surname>Dierich</surname><given-names>A</given-names></name><name><surname>Svejgaard</surname><given-names>A</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name><name><surname>Fugger</surname><given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mice lacking all conventional MHC class II genes</article-title><source>PNAS</source><volume>96</volume><fpage>10338</fpage><lpage>10343</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.18.10338</pub-id><pub-id pub-id-type="pmid">10468609</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>TC</given-names></name><name><surname>Khan</surname><given-names>IS</given-names></name><name><surname>Gardner</surname><given-names>JM</given-names></name><name><surname>Mouchess</surname><given-names>ML</given-names></name><name><surname>Johannes</surname><given-names>KP</given-names></name><name><surname>Krawisz</surname><given-names>AK</given-names></name><name><surname>Skrzypczynska</surname><given-names>KM</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lineage tracing and cell ablation identify a post-Aire-expressing thymic epithelial cell population</article-title><source>Cell Reports</source><volume>5</volume><fpage>166</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2013.08.038</pub-id><pub-id pub-id-type="pmid">24095736</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>C</given-names></name><name><surname>Miller</surname><given-names>CN</given-names></name><name><surname>Küchler</surname><given-names>R</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Pinto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Revisiting the Road Map of Medullary Thymic Epithelial Cell Differentiation</article-title><source>Journal of Immunology</source><volume>199</volume><fpage>3488</fpage><lpage>3503</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1700203</pub-id><pub-id pub-id-type="pmid">28993517</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>CN</given-names></name><name><surname>Proekt</surname><given-names>I</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Wells</surname><given-names>KL</given-names></name><name><surname>Rajpurkar</surname><given-names>AR</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Rattay</surname><given-names>K</given-names></name><name><surname>Khan</surname><given-names>IS</given-names></name><name><surname>Metzger</surname><given-names>TC</given-names></name><name><surname>Pollack</surname><given-names>JL</given-names></name><name><surname>Fries</surname><given-names>AC</given-names></name><name><surname>Lwin</surname><given-names>WW</given-names></name><name><surname>Wigton</surname><given-names>EJ</given-names></name><name><surname>Parent</surname><given-names>AV</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><name><surname>Erle</surname><given-names>DJ</given-names></name><name><surname>Hogquist</surname><given-names>KA</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development</article-title><source>Nature</source><volume>559</volume><fpage>627</fpage><lpage>631</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0345-2</pub-id><pub-id pub-id-type="pmid">30022164</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>Y</given-names></name><name><surname>Hirota</surname><given-names>F</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><name><surname>Kitajima</surname><given-names>H</given-names></name><name><surname>Miyazaki</surname><given-names>J</given-names></name><name><surname>Kawamoto</surname><given-names>H</given-names></name><name><surname>Mouri</surname><given-names>Y</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Biphasic Aire expression in early embryos and in medullary thymic epithelial cells before end-stage terminal differentiation</article-title><source>The Journal of Experimental Medicine</source><volume>207</volume><fpage>963</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1084/jem.20092144</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Org</surname><given-names>T</given-names></name><name><surname>Rebane</surname><given-names>A</given-names></name><name><surname>Kisand</surname><given-names>K</given-names></name><name><surname>Laan</surname><given-names>M</given-names></name><name><surname>Haljasorg</surname><given-names>U</given-names></name><name><surname>Andreson</surname><given-names>R</given-names></name><name><surname>Peterson</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>AIRE activated tissue specific genes have histone modifications associated with inactive chromatin</article-title><source>Human Molecular Genetics</source><volume>18</volume><fpage>4699</fpage><lpage>4710</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddp433</pub-id><pub-id pub-id-type="pmid">19744957</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otero</surname><given-names>DC</given-names></name><name><surname>Baker</surname><given-names>DP</given-names></name><name><surname>David</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>IRF7-Dependent IFN-beta Production in Response to RANKL Promotes Medullary Thymic Epithelial Cell Development</article-title><source>Journal of Immunology</source><volume>10</volume><elocation-id>1203086</elocation-id><pub-id pub-id-type="doi">10.4049/jimmunol.1203086</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezzi</surname><given-names>N</given-names></name><name><surname>Assis</surname><given-names>AF</given-names></name><name><surname>Cotrim-Sousa</surname><given-names>LC</given-names></name><name><surname>Lopes</surname><given-names>GS</given-names></name><name><surname>Mosella</surname><given-names>MS</given-names></name><name><surname>Lima</surname><given-names>DS</given-names></name><name><surname>Bombonato-Prado</surname><given-names>KF</given-names></name><name><surname>Passos</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Aire knockdown in medullary thymic epithelial cells affects Aire protein, deregulates cell adhesion genes and decreases thymocyte interaction</article-title><source>Molecular Immunology</source><volume>77</volume><fpage>157</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2016.08.003</pub-id><pub-id pub-id-type="pmid">27505711</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemann</surname><given-names>M</given-names></name><name><surname>Andreas</surname><given-names>N</given-names></name><name><surname>Fedoseeva</surname><given-names>M</given-names></name><name><surname>Meier</surname><given-names>E</given-names></name><name><surname>Weih</surname><given-names>D</given-names></name><name><surname>Freytag</surname><given-names>H</given-names></name><name><surname>Schmidt-Ullrich</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>U</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Weih</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Central immune tolerance depends on crosstalk between the classical and alternative NF-κB pathways in medullary thymic epithelial cells</article-title><source>Journal of Autoimmunity</source><volume>81</volume><fpage>56</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.jaut.2017.03.007</pub-id><pub-id pub-id-type="pmid">28385374</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>PM</given-names></name><name><surname>Ribeiro</surname><given-names>AR</given-names></name><name><surname>Perrod</surname><given-names>C</given-names></name><name><surname>Landry</surname><given-names>JJM</given-names></name><name><surname>Araújo</surname><given-names>L</given-names></name><name><surname>Pereira-Castro</surname><given-names>I</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>Moreira</surname><given-names>A</given-names></name><name><surname>Xavier-Ferreira</surname><given-names>H</given-names></name><name><surname>Meireles</surname><given-names>C</given-names></name><name><surname>Alves</surname><given-names>NL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Thymic epithelial cells require p53 to support their long-term function in thymopoiesis in mice</article-title><source>Blood</source><volume>130</volume><fpage>478</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1182/blood-2016-12-758961</pub-id><pub-id pub-id-type="pmid">28559356</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sansom</surname><given-names>SN</given-names></name><name><surname>Shikama-Dorn</surname><given-names>N</given-names></name><name><surname>Zhanybekova</surname><given-names>S</given-names></name><name><surname>Nusspaumer</surname><given-names>G</given-names></name><name><surname>Macaulay</surname><given-names>IC</given-names></name><name><surname>Deadman</surname><given-names>ME</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Population and single-cell genomics reveal the Aire dependency, relief from Polycomb silencing, and distribution of self-antigen expression in thymic epithelia</article-title><source>Genome Research</source><volume>24</volume><fpage>1918</fpage><lpage>1931</lpage><pub-id pub-id-type="doi">10.1101/gr.171645.113</pub-id><pub-id pub-id-type="pmid">25224068</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sergé</surname><given-names>A</given-names></name><name><surname>Bailly</surname><given-names>A-L</given-names></name><name><surname>Aurrand-Lions</surname><given-names>M</given-names></name><name><surname>Imhof</surname><given-names>BA</given-names></name><name><surname>Irla</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>For3D: Full organ reconstruction in 3D, an automatized tool for deciphering the complexity of lymphoid organs</article-title><source>Journal of Immunological Methods</source><volume>424</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2015.04.019</pub-id><pub-id pub-id-type="pmid">25956038</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>MG</given-names></name><name><surname>Shah</surname><given-names>YM</given-names></name><name><surname>Omary</surname><given-names>MB</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Qi</surname><given-names>L</given-names></name><name><surname>Rui</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Medullary thymic epithelial NF-kB-inducing kinase (NIK)/IKKα pathway shapes autoimmunity and liver and lung homeostasis in mice</article-title><source>PNAS</source><volume>116</volume><fpage>19090</fpage><lpage>19097</lpage><pub-id pub-id-type="doi">10.1073/pnas.1901056116</pub-id><pub-id pub-id-type="pmid">31481626</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Manrai</surname><given-names>AK</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>CEAS: cis-regulatory element annotation system</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2605</fpage><lpage>2606</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp479</pub-id><pub-id pub-id-type="pmid">19689956</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinkai</surname><given-names>Y</given-names></name><name><surname>Rathbun</surname><given-names>G</given-names></name><name><surname>Lam</surname><given-names>KP</given-names></name><name><surname>Oltz</surname><given-names>EM</given-names></name><name><surname>Stewart</surname><given-names>V</given-names></name><name><surname>Mendelsohn</surname><given-names>M</given-names></name><name><surname>Charron</surname><given-names>J</given-names></name><name><surname>Datta</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>F</given-names></name><name><surname>Stall</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement</article-title><source>Cell</source><volume>68</volume><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(92)90029-c</pub-id><pub-id pub-id-type="pmid">1547487</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaba</surname><given-names>H</given-names></name><name><surname>Morishita</surname><given-names>Y</given-names></name><name><surname>Tomofuji</surname><given-names>Y</given-names></name><name><surname>Danks</surname><given-names>L</given-names></name><name><surname>Nitta</surname><given-names>T</given-names></name><name><surname>Komatsu</surname><given-names>N</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Takayanagi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fezf2 Orchestrates a Thymic Program of Self-Antigen Expression for Immune Tolerance</article-title><source>Cell</source><volume>163</volume><fpage>975</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.10.013</pub-id><pub-id pub-id-type="pmid">26544942</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapnell</surname><given-names>C</given-names></name><name><surname>Hendrickson</surname><given-names>DG</given-names></name><name><surname>Sauvageau</surname><given-names>M</given-names></name><name><surname>Goff</surname><given-names>L</given-names></name><name><surname>Rinn</surname><given-names>JL</given-names></name><name><surname>Pachter</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Differential analysis of gene regulation at transcript resolution with RNA-seq</article-title><source>Nature Biotechnology</source><volume>31</volume><fpage>46</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1038/nbt.2450</pub-id><pub-id pub-id-type="pmid">23222703</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tykocinski</surname><given-names>LO</given-names></name><name><surname>Sinemus</surname><given-names>A</given-names></name><name><surname>Rezavandy</surname><given-names>E</given-names></name><name><surname>Weiland</surname><given-names>Y</given-names></name><name><surname>Baddeley</surname><given-names>D</given-names></name><name><surname>Cremer</surname><given-names>C</given-names></name><name><surname>Sonntag</surname><given-names>S</given-names></name><name><surname>Willecke</surname><given-names>K</given-names></name><name><surname>Derbinski</surname><given-names>J</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Epigenetic regulation of promiscuous gene expression in thymic medullary epithelial cells</article-title><source>PNAS</source><volume>107</volume><fpage>19426</fpage><lpage>19431</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009265107</pub-id><pub-id pub-id-type="pmid">20966351</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ucar</surname><given-names>O</given-names></name><name><surname>Rattay</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Promiscuous Gene Expression in the Thymus: A Matter of Epigenetics, miRNA, and More?</article-title><source>Frontiers in Immunology</source><volume>6</volume><elocation-id>93</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2015.00093</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>F</given-names></name><name><surname>Gray</surname><given-names>DHD</given-names></name><name><surname>Kuse</surname><given-names>S</given-names></name><name><surname>Hieshima</surname><given-names>K</given-names></name><name><surname>Nakano</surname><given-names>H</given-names></name><name><surname>Kakiuchi</surname><given-names>T</given-names></name><name><surname>Lipp</surname><given-names>M</given-names></name><name><surname>Boyd</surname><given-names>RL</given-names></name><name><surname>Takahama</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>CCR7 signals are essential for cortex-medulla migration of developing thymocytes</article-title><source>The Journal of Experimental Medicine</source><volume>200</volume><fpage>493</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1084/jem.20040643</pub-id><pub-id pub-id-type="pmid">15302902</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ewijk</surname><given-names>W</given-names></name><name><surname>Shores</surname><given-names>EW</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Crosstalk in the mouse thymus</article-title><source>Immunology Today</source><volume>15</volume><fpage>214</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/0167-5699(94)90246-1</pub-id><pub-id pub-id-type="pmid">8024681</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waldburger</surname><given-names>JM</given-names></name><name><surname>Rossi</surname><given-names>S</given-names></name><name><surname>Hollander</surname><given-names>GA</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name><name><surname>Reith</surname><given-names>W</given-names></name><name><surname>Acha-Orbea</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Promoter IV of the class II transactivator gene is essential for positive selection of CD4+ T cells</article-title><source>Blood</source><volume>101</volume><fpage>3550</fpage><lpage>3559</lpage><pub-id pub-id-type="doi">10.1182/blood-2002-06-1855</pub-id><pub-id pub-id-type="pmid">12506036</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname><given-names>KL</given-names></name><name><surname>Miller</surname><given-names>CN</given-names></name><name><surname>Gschwind</surname><given-names>AR</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Phipps</surname><given-names>JD</given-names></name><name><surname>Anderson</surname><given-names>MS</given-names></name><name><surname>Steinmetz</surname><given-names>LM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Combined transient ablation and single-cell RNA-sequencing reveals the development of medullary thymic epithelial cells</article-title><source>eLife</source><volume>9</volume><elocation-id>e60188</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.60188</pub-id><pub-id pub-id-type="pmid">33226342</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>AJ</given-names></name><name><surname>Jenkinson</surname><given-names>WE</given-names></name><name><surname>Cowan</surname><given-names>JE</given-names></name><name><surname>Parnell</surname><given-names>SM</given-names></name><name><surname>Bacon</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>ND</given-names></name><name><surname>Jenkinson</surname><given-names>EJ</given-names></name><name><surname>Anderson</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells</article-title><source>Journal of Immunology</source><volume>192</volume><fpage>2659</fpage><lpage>2666</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1303057</pub-id><pub-id pub-id-type="pmid">24510964</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Lister</surname><given-names>NL</given-names></name><name><surname>Barsanti</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>JMC</given-names></name><name><surname>Hammett</surname><given-names>MV</given-names></name><name><surname>Khong</surname><given-names>DM</given-names></name><name><surname>Siatskas</surname><given-names>C</given-names></name><name><surname>Gray</surname><given-names>DHD</given-names></name><name><surname>Boyd</surname><given-names>RL</given-names></name><name><surname>Chidgey</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multilineage potential and self-renewal define an epithelial progenitor cell population in the adult thymus</article-title><source>Cell Reports</source><volume>8</volume><fpage>1198</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.07.029</pub-id><pub-id pub-id-type="pmid">25131206</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youm</surname><given-names>YH</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Mangelsdorf</surname><given-names>DJ</given-names></name><name><surname>Kliewer</surname><given-names>SA</given-names></name><name><surname>Dixit</surname><given-names>VD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution</article-title><source>PNAS</source><volume>113</volume><fpage>1026</fpage><lpage>1031</lpage><pub-id pub-id-type="doi">10.1073/pnas.1514511113</pub-id><pub-id pub-id-type="pmid">26755598</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A comparative encyclopedia of DNA elements in the mouse genome</article-title><source>Nature</source><volume>515</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1038/nature13992</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Peterson</surname><given-names>P</given-names></name><name><surname>Gunning</surname><given-names>WT</given-names></name><name><surname>Ding</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NF-kappaB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>38617</fpage><lpage>38624</lpage><pub-id pub-id-type="doi">10.1074/jbc.M606705200</pub-id><pub-id pub-id-type="pmid">17046818</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Meyer</surname><given-names>CA</given-names></name><name><surname>Eeckhoute</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DS</given-names></name><name><surname>Bernstein</surname><given-names>BE</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Myers</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Model-based analysis of ChIP-Seq (MACS)</article-title><source>Genome Biology</source><volume>9</volume><elocation-id>R137</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2008-9-9-r137</pub-id><pub-id pub-id-type="pmid">18798982</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Chin</surname><given-names>RK</given-names></name><name><surname>Christiansen</surname><given-names>PA</given-names></name><name><surname>Lo</surname><given-names>JC</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Ware</surname><given-names>C</given-names></name><name><surname>Siebenlist</surname><given-names>U</given-names></name><name><surname>Fu</surname><given-names>YX</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway</article-title><source>The Journal of Clinical Investigation</source><volume>116</volume><fpage>2964</fpage><lpage>2971</lpage><pub-id pub-id-type="doi">10.1172/JCI28326</pub-id><pub-id pub-id-type="pmid">17039258</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Žuklys</surname><given-names>S</given-names></name><name><surname>Handel</surname><given-names>A</given-names></name><name><surname>Zhanybekova</surname><given-names>S</given-names></name><name><surname>Govani</surname><given-names>F</given-names></name><name><surname>Keller</surname><given-names>M</given-names></name><name><surname>Maio</surname><given-names>S</given-names></name><name><surname>Mayer</surname><given-names>CE</given-names></name><name><surname>Teh</surname><given-names>HY</given-names></name><name><surname>Hafen</surname><given-names>K</given-names></name><name><surname>Gallone</surname><given-names>G</given-names></name><name><surname>Barthlott</surname><given-names>T</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Holländer</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Foxn1 regulates key target genes essential for T cell development in postnatal thymic epithelial cells</article-title><source>Nature Immunology</source><volume>17</volume><fpage>1206</fpage><lpage>1215</lpage><pub-id pub-id-type="doi">10.1038/ni.3537</pub-id><pub-id pub-id-type="pmid">27548434</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69982.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Russell</surname><given-names>Sarah</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a8bt934</institution-id><institution>Peter MacCallum Cancer Centre</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2020.11.29.399923" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2020.11.29.399923"/></front-stub><body><p>This manuscript is of interest to readers in the field of immunology and especially in the induction of immune tolerance in the thymus. The work uses several mouse models to substantially broaden the current understanding of MHCII/TCR-mediated cell-cell crosstalk in the thymus and suggests a novel mechanism that contributes to the generation of functional and self-tolerant T-cells.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69982.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Russell</surname><given-names>Sarah</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a8bt934</institution-id><institution>Peter MacCallum Cancer Centre</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Russell</surname><given-names>Sarah</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02a8bt934</institution-id><institution>Peter MacCallum Cancer Centre</institution></institution-wrap><country>Australia</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2020.11.29.399923">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.11.29.399923v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Sarah Russell as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Tadatsugu Taniguchi as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>With regard to the elucidation of how CD4 cells signal to mTECS to shape their differentiation:</p><p>1. According to the recent scRNA sequencing studies (reviewed in Kadouri et al. 2020), the mTEClow mTECs contain at least two distinct subpopulations: the functionally mature CCL21-producing mTEC I and the immature mTECs giving rise to mTEC II and III. In its current form, however, the manuscript largely ignores the presence of mTEC I cells. It would be important to analyze the changes in this population in the knockout models (by sequencing and/or qPCR) and cover this population also in the introduction and discussion.</p><p>2. The authors conclude that their RNAseq data in figures 1 and 4 show that genes are upregulated/downregulated. However, it could also be that their differential gene/cytokine expression is due to the presence of different mTEC<sup>lo</sup> subsets, and the authors show this in figure 3. This would change the conclusion to: CD4<sup>+</sup> thymocytes alter mTEC<sup>lo</sup> differentiation states, associated with differential gene expression. This is also the case in figure 2. For instance, Lopez et al. state that AIRE expression 4.5-fold higher in mTEC<sup>ΔMHCII</sup> cells but then they show that there are different percentages of AIRE<sup>+</sup> cells (change in the mTEC<sup>lo</sup> subsets in the ko mice). It is important to make clear that the signalling/expression data are confounded by differences in mTEC cell populations changes might reflect different cell composition rather than different signalling or expression states.</p><p>3. In figure 3, the authors show mTEC<sup>hi</sup> cells in dCD4 and mTEC<sup>ΔMHCII</sup> mice. It is surprising that mTEC<sup>hi</sup> cells are present since these shouldn't differentiate in the absence of an MHCII-TCR interaction. It is important to address how these cells develop and whether their presence alters interpretation of the results.</p><p>With regard to how these interactions shape the TCRVβ repertoire in mature T cells:</p><p>4. Differences in the percentage of a few TCRVβ families are not sufficient to conclude that there is an alteration in the TCRVβ repertoire. Sequencing the different TCRs and evaluate constraints on TCR-CDR3 segments will be required for this conclusion.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The assumption by the authors that the observed phenotypes are driven by CD4 deficiency is central to the conclusions of the manuscript, but is not tested in the manuscript. This seems an important caveat to address.</p><p>The authors should make clear whether the genetic disruptions they use directly or indirectly influence the cell types that they claim to be relevant for each phenotype, and what other alternative explanations might lead to the phenotypes.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Occasionally (as in page 12 para 2) the authors interpret a decrease (of transcription factors) in their knockout model as an increase in wild-type mouse. Although hypothetically right, this should be corrected especially in the Results section.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. The authors present data demonstrating that the lack of CD4 on thymocytes changes NFkb signalling in mTEC<sup>lo</sup> cells, with decreased IKKa/p38 signalling and increased pRELB. MFI would likely be better evaluated as a staining index or ratio, to control staining in that mouse type.</p><p>2. Staining for DclK<sup>+</sup> cells in the AIRE- subset should show all gates.</p><p>3. In figure 4, the staining for pRELB relative to total RELB would suggest higher phosphorylation in the OTII-RAG2<sup>-/-</sup> mice (i.e., total RELB is more decreased than pRELB). Staining for RelB appears very heterogeneous, suggesting that it is expressed at different levels in different subsets. Also, staining controls for both types of mice are not shown. This is also the case in figure 6C.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.69982.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>With regard to the elucidation of how CD4 cells signal to mTECS to shape their differentiation:</p><p>1. According to the recent scRNA sequencing studies (reviewed in Kadouri et al. 2020), the mTEClow mTECs contain at least two distinct subpopulations: the functionally mature CCL21-producing mTEC I and the immature mTECs giving rise to mTEC II and III. In its current form, however, the manuscript largely ignores the presence of mTEC I cells. It would be important to analyze the changes in this population in the knockout models (by sequencing and/or qPCR) and cover this population also in the introduction and discussion.</p></disp-quote><p>We thank the Reviewers for highlighting that mTEC<sup>lo</sup> also contain CCL21-producing cells, called mTEC I. In this revised version, we analyzed CCL21<sup>+</sup> mTEC<sup>lo</sup> by flow cytometry in the different mouse models described in this study, i.e., ΔCD4 (absence of CD4<sup>+</sup> thymocytes), mTEC<sup>ΔMHCII</sup> (absence of MHCII-TCR interactions between mTEC and CD4<sup>+</sup> thymocytes), MHCII<sup>-/-</sup>, OTII and RipmOVA x OTII mice. As shown in the new Figure 3D and Figure 3—figure supplement 3B, the frequencies of CCL21<sup>+</sup> cells among mTEC<sup>lo</sup> cells were globally unaffected in ΔCD4, mTEC<sup>ΔMHCII</sup> and MHCII<sup>-/-</sup> mice, although their numbers were reduced, consistently with a smaller medulla compartment in these mice, previously reported by our group (cf. Irla et al. Plos One 2012 and J Immunol. 2013). Numbers of CCL21<sup>+</sup> mTEC<sup>lo</sup> were also increased in RipmOVA x OTII mice compared to OTII mice (cf. New Figure 5G), consistently with our previous observation that antigen-specific interactions between mTECs and CD4<sup>+</sup> thymocytes induce medulla development (cf. Irla et al. Plos One 2012).</p><p>We now cover the CCL21<sup>+</sup> mTEC<sup>lo</sup> subset in the introduction and discuss these new results.</p><disp-quote content-type="editor-comment"><p>2. The authors conclude that their RNAseq data in figures 1 and 4 show that genes are upregulated/downregulated. However, it could also be that their differential gene/cytokine expression is due to the presence of different mTEC<sup>lo</sup> subsets, and the authors show this in figure 3. This would change the conclusion to: CD4<sup>+</sup> thymocytes alter mTEC<sup>lo</sup> differentiation states, associated with differential gene expression. This is also the case in figure 2. For instance, Lopez et al. state that AIRE expression 4.5-fold higher in mTEC<sup>ΔMHCII</sup> cells but then they show that there are different percentages of AIRE<sup>+</sup> cells (change in the mTEC<sup>mhcii</sup>subsets in the ko mice). It is important to make clear that the signalling/expression data are confounded by differences in mTEC cell populations changes might reflect different cell composition rather than different signalling or expression states.</p></disp-quote><p>We fully agree that mTEC<sup>lo</sup> cells are heterogeneous and that changes in mTEC<sup>lo</sup> subset composition in the transgenic mouse models analyzed could contribute to the differences observed. To clarify this point, we aimed at investigating in this revised version whether the upregulation/downregulation of genes observed by RNAseq in figures 1, 2 and 4 could be due to the impact of the crosstalk at the gene expression level or rather due to the presence of different mTEC<sup>lo</sup> subsets. To this end, we analyzed single cell RNA-seq data on mTEC recently published by Wells KL et al. (<italic>eLife</italic>. 2020) (cf. new Figure 1—figure supplement 4) to determine whether the genes found to be affected by the thymic crosstalk, are specific to a particular mTEC subset (i.e. CCL21<sup>+</sup>, TAC-TEC, Aire<sup>+</sup>, Post-Aire and Tuft-like cells). In accordance with the reduced proportions of Post-Aire and DCLK1<sup>+</sup> Tuft-like cells observed respectively by histology and flow cytometry (cf. Figure 3E, Figure 5H, Figure 3—figure supplement 2A and Figure 5—figure supplement 3A), some of these genes were associated with Post-Aire and Tuft-like cells (cf. new Figure 1I, new Figure 2K, new Figure 4L). Importantly, this new analysis revealed that many genes upregulated by CD4<sup>+</sup> thymocytes were highly expressed by Aire<sup>+</sup> mTECs, strongly suggesting that their increase in mTEC<sup>lo</sup> is due to an enhanced transcriptional activity accompanying the transition to Aire<sup>+</sup> mTECs rather than changes in mTEC<sup>lo</sup> subset composition. In line with this hypothesis, we found that several of these genes were already expressed in TAC-TECs that precede Aire<sup>+</sup> mTECs.</p><p>These new results, suggesting a direct upregulation of a number of mTEC<sup>hi</sup>-specific genes in mTEC<sup>lo</sup>, as well as the possibility that signaling data could be confounded by differences in mTEC<sup>lo</sup> subsets, are now discussed in this revised version.</p><disp-quote content-type="editor-comment"><p>3. In figure 3, the authors show mTEC<sup>hi</sup> cells in dCD4 and mTEC<sup>ΔMHCII</sup> mice. It is surprising that mTEC<sup>hi</sup> cells are present since these shouldn't differentiate in the absence of an MHCII-TCR interaction. It is important to address how these cells develop and whether their presence alters interpretation of the results.</p></disp-quote><p>To clarify this point, we now show frequencies and numbers of mTEC<sup>hi</sup> analyzed by flow cytometry in WT, dCD4 and mTEC<sup>ΔMHCII</sup> mice (cf. new Figure 3A). The development of these cells is substantially impaired but not totally abrogated in these mice, which is in total agreement with previous observations from our group (Irla et al. Immunity 2008 and Plos One 2012). Since the development of mTEC<sup>hi</sup>, including Aire<sup>+</sup> cells, relies on RANK signaling (Khan et al. J Exp Med. 2014, Akiyama et al. Immunity 2008, Hikosaka et al. Immunity 2008, Rossi et al. J Exp Med. 2007, Irla Front Immunol 2021), the residual development of mTEC in dCD4 and mTEC<sup>ΔMHCII</sup> mice could be explained by the fact that in addition to CD4<sup>+</sup> thymocytes, RANKL is also expressed by invariant NKT cells, which are present in these mice. In agreement with this hypothesis, invariant NKT cells have been shown to participate in Aire<sup>+</sup> mTEC differentiation in the post-natal thymus, but to a lesser extent than CD4<sup>+</sup> thymocytes (White AJ et al. J Immunol 2014). We clarified this point in the discussion (lines 441-444).</p><p>The residual development of mTEC<sup>hi</sup> in these mice does not interfere with the interpretation of the results. Indeed, we took into consideration the impact of the residual development of mTEC<sup>hi</sup> in the composition of mTEC<sup>lo</sup> by analyzing post-Aire cells that derived from Aire<sup>+</sup> mTEC<sup>hi</sup> (cf. Figure 3—figure supplement 2A and Figure 5—figure supplement 3A). In agreement with the impaired development of Aire<sup>+</sup> mTEC<sup>hi</sup> in dCD4, mTEC<sup>ΔMHCII</sup> mice, numbers of Involucrin<sup>+</sup>TPA<sup>+</sup>Aire<sup>-</sup> post-Aire cells were reduced. In this revised version, we also analyzed whether genes found to be differentially expressed by RNA-seq are associated with post-Aire cells using single-cell RNAseq data (cf. new Figures 1I, 2K and 4L). In line with the reduction in post-Aire cells, some differentially expressed genes were associated with these cells.</p><disp-quote content-type="editor-comment"><p>With regard to how these interactions shape the TCRVβ repertoire in mature T cells:</p><p>4. Differences in the percentage of a few TCRVβ families are not sufficient to conclude that there is an alteration in the TCRVβ repertoire. Sequencing the different TCRs and evaluate constraints on TCR-CDR3 segments will be required for this conclusion.</p></disp-quote><p>We fully agree that the differences observed by flow cytometry in the percentages of TCRVβ usage are insufficient to conclude that the TCRVβ repertoire is altered. We have modified the text in the Results section (cf. lines 97, 368) and discussed that future experiments based on TCR sequencing are expected to clarify this point (cf. lines 482-489), which is beyond the scope of the current study.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The assumption by the authors that the observed phenotypes are driven by CD4 deficiency is central to the conclusions of the manuscript, but is not tested in the manuscript. This seems an important caveat to address.</p><p>The authors should make clear whether the genetic disruptions they use directly or indirectly influence the cell types that they claim to be relevant for each phenotype, and what other alternative explanations might lead to the phenotypes.</p></disp-quote><p>We understand the point raised by the Reviewer that a genetic mutation in the class II transactivator CIITA in dCD4 and mTEC<sup>ΔMHCII</sup> mice could indirectly influence the mTEC subsets analyzed. This is the reason why we have completed our study by analyzing mTEC<sup>lo</sup> from MHCII<sup>-/-</sup> mice both by qPCR and flow cytometry (cf. Figure 1—figure supplement 3A and Figure 3—figure supplement 3). Similar defects in TRA expression and in the cellularity of mTEC subsets (i.e. Aire<sup>-</sup>Fezf2<sup>+</sup> and Aire<sup>+</sup>Fezf2<sup>+</sup> mTECs, as well as in CCL21<sup>+</sup> and DCLK1<sup>+</sup> mTEC<sup>lo</sup>) were observed in these mice, ruling out any potential indirect effect of CIITA in the observed results (cf. lines 132-134).</p><p>Furthermore, to strengthen our general conclusion that self-reactive CD4<sup>+</sup> thymocytes have a direct effect on mTEC and further exclude any potential indirect impact of CIITA or even MHCII molecules in the observed results, we compared the transcriptome of mTEC<sup>lo</sup> from OTII-Rag2<sup>-/-</sup> and RipmOVA x OTII-Rag2<sup>-/-</sup> mice by RNA-seq and analyzed their respective composition in mTEC subsets by flow cytometry. Importantly, the only difference in these two transgenic mice relies on the expression (RipmOVA x OTII-Rag2<sup>-/-</sup> mice) or not (OTII-Rag2<sup>-/-</sup> mice) of the cognate OVA antigen, which is driven by the rat insulin promoter (Rip) specifically in mTEC. Again, the analysis of these mice led to the same overall phenotype as observed in the WT vs. dCD4 or the WT vs. mTEC<sup>ΔMHCII</sup> comparison.</p><p>In summary, the comparison of these three distinct transgenic models by the different approaches used strongly supports the notion that self-reactive CD4<sup>+</sup> thymocytes directly affect the mTEC subsets analyzed.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Occasionally (as in page 12 para 2) the authors interpret a decrease (of transcription factors) in their knockout model as an increase in wild-type mouse. Although hypothetically right, this should be corrected especially in the Results section.</p></disp-quote><p>We accordingly modified the text (cf. Lines 189-194).</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. The authors present data demonstrating that the lack of CD4 on thymocytes changes NFkb signalling in mTEC<sup>lo</sup> cells, with decreased IKKa/p38 signalling and increased pRELB. MFI would likely be better evaluated as a staining index or ratio, to control staining in that mouse type.</p></disp-quote><p>Thank you for this comment. We now represent MFI as a ratio to secondary antibody control staining (cf. new Figures 1A and 4B).</p><disp-quote content-type="editor-comment"><p>2. Staining for DclK<sup>+</sup> cells in the AIRE- subset should show all gates.</p></disp-quote><p>We now show the gating strategy concerning the identification of DCLK1<sup>+</sup> mTEC (cf. new Figure 3—figure supplement 2B and new Figure 5—figure supplement 3B).</p><disp-quote content-type="editor-comment"><p>3. In figure 4, the staining for pRELB relative to total RELB would suggest higher phosphorylation in the OTII-RAG2<sup>-/-</sup> mice (i.e., total RELB is more decreased than pRELB). Staining for RelB appears very heterogeneous, suggesting that it is expressed at different levels in different subsets. Also, staining controls for both types of mice are not shown. This is also the case in figure 6C.</p></disp-quote><p>To clarify whether the heterogeneous staining of RelB expression observed by flow cytometry could be due to different expression levels in distinct mTEC<sup>lo</sup> subsets, we analyzed <italic>Relb</italic> gene expression level in CCL21<sup>+</sup>, TAC-TEC, post-Aire and Tuft-like mTEC using single-cell RNA-seq data. We found that <italic>Relb</italic> is highly expressed in TAC-TEC and post-Aire cells (cf. New Figure 4-supplement 2A). These observations are in agreement with the hypothesis that self-reactive CD4<sup>+</sup> thymocytes activate NFkB signaling from the TAC-TEC stage that precedes Aire<sup>+</sup> mTECs and that this activation persists in post-Aire cells. We modified the text accordingly (cf. lines 259-263).</p><p>Unfortunately, it is technically not possible to detect RelB in Tuft-like mTEC because anti-RelB and anti-DCLK1 antibodies are both produced in rabbit and are detected through anti-rabbit secondary antibodies. It is also not possible to evaluate RelB level in post-Aire and TAC-TEC cells because there is no valuable markers to date that allow the identification of these cells by flow cytometry. Therefore, we discuss that we cannot exclude that the heterogeneity in RelB expression could also be due to different representation of mTEC<sup>lo</sup> subsets (cf. lines 396-400).</p><p>Moreover, we verified that the secondary antibody control staining gives the same signal in RipmOVA x OTII-Rag2<sup>-/-</sup> and OTII-Rag2<sup>-/-</sup> mice (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>).</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-69982-sa2-fig1-v2.tif"/></fig></body></sub-article></article>